{"resourceType":"MedicationAdministration","id":"1d51a388-4a8a-514b-1853-555c0c507630","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/a2a4e20f-4721-27f9-d017-9ad073e66b5a"},"context":{"reference":"Encounter/4c5b6208-b9f8-234d-e495-8485d9734678"},"effectiveDateTime":"2022-06-29T23:52:41-04:00"}
{"resourceType":"MedicationAdministration","id":"cbf0608d-ec7a-8065-53d1-0c92b6de8265","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0d9f0363-665a-a5c5-db05-e148d5e8de29"},"context":{"reference":"Encounter/6d8b7c4e-2bf1-0c64-c45d-ad17d281cba2"},"effectiveDateTime":"2010-10-02T13:37:30-04:00","reasonReference":[{"reference":"Condition/a59408cc-6686-1c4a-500c-215cc546e7ba","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fcd7546d-4a8d-a6ab-54e0-e987b44cd66d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0d9f0363-665a-a5c5-db05-e148d5e8de29"},"context":{"reference":"Encounter/6d8b7c4e-2bf1-0c64-c45d-ad17d281cba2"},"effectiveDateTime":"2010-10-03T01:37:30-04:00","reasonReference":[{"reference":"Condition/a59408cc-6686-1c4a-500c-215cc546e7ba","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89a83bce-ba03-6e48-c7a4-fad41a29c3fb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0d9f0363-665a-a5c5-db05-e148d5e8de29"},"context":{"reference":"Encounter/6d8b7c4e-2bf1-0c64-c45d-ad17d281cba2"},"effectiveDateTime":"2010-10-03T13:37:30-04:00","reasonReference":[{"reference":"Condition/a59408cc-6686-1c4a-500c-215cc546e7ba","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"54d58ce1-ef75-46ea-878d-7389d16d71eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0d9f0363-665a-a5c5-db05-e148d5e8de29"},"context":{"reference":"Encounter/6d8b7c4e-2bf1-0c64-c45d-ad17d281cba2"},"effectiveDateTime":"2010-10-04T01:37:30-04:00","reasonReference":[{"reference":"Condition/a59408cc-6686-1c4a-500c-215cc546e7ba","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61e004fc-9362-6174-ea7a-60e90ed19825","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198240","display":"Tamoxifen 10 MG Oral Tablet"}],"text":"Tamoxifen 10 MG Oral Tablet"},"subject":{"reference":"Patient/7701b998-36e9-b4d2-8d01-ec0ae297c581"},"context":{"reference":"Encounter/40c51758-dce6-0981-5fa5-9366ac2e8d4a"},"effectiveDateTime":"2018-04-25T23:05:54-04:00","reasonReference":[{"reference":"Condition/5aa73512-a905-6b2d-2a4f-08bd5f6ba9a8","display":"Malignant neoplasm of breast (disorder)"}],"dosage":{"dose":{"value":1}}}
{"resourceType":"MedicationAdministration","id":"b97bd00c-45cd-7f24-dbe5-3fbe338a59ea","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2119714","display":"5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab 120 MG/ML Injection"}],"text":"5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab 120 MG/ML Injection"},"subject":{"reference":"Patient/7701b998-36e9-b4d2-8d01-ec0ae297c581"},"context":{"reference":"Encounter/40c51758-dce6-0981-5fa5-9366ac2e8d4a"},"effectiveDateTime":"2018-04-25T23:05:54-04:00","reasonReference":[{"reference":"Condition/5aa73512-a905-6b2d-2a4f-08bd5f6ba9a8","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f82ad429-dc77-01fb-5b3c-08e1b56de069","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1873983","display":"ribociclib 200 MG Oral Tablet"}],"text":"ribociclib 200 MG Oral Tablet"},"subject":{"reference":"Patient/7701b998-36e9-b4d2-8d01-ec0ae297c581"},"context":{"reference":"Encounter/40c51758-dce6-0981-5fa5-9366ac2e8d4a"},"effectiveDateTime":"2018-04-25T23:05:54-04:00","reasonReference":[{"reference":"Condition/5aa73512-a905-6b2d-2a4f-08bd5f6ba9a8","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6edaf8c1-265e-f069-ee6d-34030b33846d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/97b553ed-e209-3ee8-712b-a9346144d446"},"effectiveDateTime":"2012-12-01T19:04:33-05:00"}
{"resourceType":"MedicationAdministration","id":"c6ee347b-1533-7f2d-d00a-91ca75d92855","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/2fc0ebf7-d93d-b2f0-d280-36b85b69be0b"},"effectiveDateTime":"2013-11-29T22:53:40-05:00"}
{"resourceType":"MedicationAdministration","id":"32d19e32-8fb6-d576-0765-a2ddb659563b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/5c80f357-1119-483e-863f-4711f187d724"},"effectiveDateTime":"2015-11-19T23:22:47-05:00"}
{"resourceType":"MedicationAdministration","id":"3173c96b-1198-fa1d-bb8b-70625938f5ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1860480","display":"1 ML DOCEtaxel 20 MG/ML Injection"}],"text":"1 ML DOCEtaxel 20 MG/ML Injection"},"subject":{"reference":"Patient/123693da-9b51-10c1-651d-67618c64541c"},"context":{"reference":"Encounter/6afe19d6-3298-e2b7-559a-e70a567dd090"},"effectiveDateTime":"2022-07-30T12:53:27-04:00","reasonReference":[{"reference":"Condition/b8695f35-5672-5967-7093-540000b7c9a0","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"70299cea-1022-a3cf-6e00-61f5e3a6479f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"752899","display":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"}],"text":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/123693da-9b51-10c1-651d-67618c64541c"},"context":{"reference":"Encounter/6afe19d6-3298-e2b7-559a-e70a567dd090"},"effectiveDateTime":"2022-07-30T12:53:27-04:00","reasonReference":[{"reference":"Condition/b8695f35-5672-5967-7093-540000b7c9a0","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"eaadcd44-00f2-6324-14f6-f2481e10e314","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1860480","display":"1 ML DOCEtaxel 20 MG/ML Injection"}],"text":"1 ML DOCEtaxel 20 MG/ML Injection"},"subject":{"reference":"Patient/123693da-9b51-10c1-651d-67618c64541c"},"context":{"reference":"Encounter/ca0e13c6-ab70-ce3f-5e62-3f73f1f16d25"},"effectiveDateTime":"2022-10-28T17:40:27-04:00","reasonReference":[{"reference":"Condition/b8695f35-5672-5967-7093-540000b7c9a0","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"14a658d7-68c6-b311-0c3b-7d69ead54251","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"752899","display":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"}],"text":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/123693da-9b51-10c1-651d-67618c64541c"},"context":{"reference":"Encounter/ca0e13c6-ab70-ce3f-5e62-3f73f1f16d25"},"effectiveDateTime":"2022-10-28T17:40:27-04:00","reasonReference":[{"reference":"Condition/b8695f35-5672-5967-7093-540000b7c9a0","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"58e844f2-dc69-8e9d-af7c-25062eb9a1e2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"}],"text":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/dd5ce68c-0d72-6724-c9eb-ced1f3604d8d"},"effectiveDateTime":"2018-06-26T01:48:11-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"557509ae-2a44-2b3c-a588-52b2ad077e8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"}],"text":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/88c84db7-16d8-785a-c7f1-85424db15c81"},"effectiveDateTime":"2018-07-18T22:31:08-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1772552a-9ea3-c2a9-6174-beb8dfcbac13","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"}],"text":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/90093e0e-aa29-7598-9a61-fb85f079119c"},"effectiveDateTime":"2018-08-09T05:42:52-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"043efba1-a8a0-084d-9843-cf95f59cdd21","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"}],"text":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/9810b339-eed2-5e93-34d5-8ef539363f62"},"effectiveDateTime":"2018-08-30T04:32:44-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3c322aa-1bc3-b76c-a0d3-641465c621da","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"}],"text":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/81ea3734-4075-ecab-1dad-dbd4f749d2ca"},"effectiveDateTime":"2018-09-21T14:56:03-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"defc4c1d-22a0-49be-8c12-f0bd494e6e18","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"}],"text":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/af4c0062-8f40-dcea-0552-5a8470b2a7d4"},"effectiveDateTime":"2018-10-14T06:18:37-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"44d4c576-3537-af53-0d99-fa9b366d54d6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"}],"text":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/579dec09-c4b0-06fc-8a31-b71ffc7785b3"},"effectiveDateTime":"2018-11-03T14:28:48-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4bb3958e-49d4-ba67-a339-3eb65383b905","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"}],"text":"10 ML Doxorubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/4e465196-6d6c-6eb0-b8db-aee9abdd5a93"},"effectiveDateTime":"2018-11-26T05:01:43-05:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4fc37af3-7f58-2b31-9fd6-dea39de7be83","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1732186","display":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"}],"text":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/e5471b98-095f-1cd5-ee88-9980801bb024"},"effectiveDateTime":"2018-12-31T14:53:21-05:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2a1ecae1-039b-103e-bc9f-661c10a5cc98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1732186","display":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"}],"text":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/815b5591-1b3a-fc21-8f49-3310190aa3d1"},"effectiveDateTime":"2019-01-23T13:41:21-05:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fec8675c-57b8-4e44-b425-7fec9d61764e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1732186","display":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"}],"text":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/637ded4d-1b0e-6065-b4bc-c562f54ddd3a"},"effectiveDateTime":"2019-02-13T08:40:21-05:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5d58abe-50e9-edf2-1825-9e2c2afd9086","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1732186","display":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"}],"text":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/4a48a860-e8c9-2d67-a69a-84d3f33438d5"},"effectiveDateTime":"2019-03-04T18:38:21-05:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9cfda7d7-1872-f0ca-b06f-21514806431a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1732186","display":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"}],"text":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/84eeb813-21af-823a-43f7-21d10e0297f1"},"effectiveDateTime":"2019-03-27T07:53:21-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6663b445-26f3-2882-4b38-484a0423ba17","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1732186","display":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"}],"text":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/13ffd850-1e4e-c353-d574-b92e96a370ef"},"effectiveDateTime":"2019-04-16T17:41:21-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b936ea7a-d259-5bea-0b86-fdf2d051557e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1732186","display":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"}],"text":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/10ba4d4e-3c36-1ab7-62d1-31201d207741"},"effectiveDateTime":"2019-05-06T19:51:21-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d9dd70be-b7e3-45c0-27cc-b9f3dce47d76","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1732186","display":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"}],"text":"100 ML Epirubicin Hydrochloride 2 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/24a1fba1-5a42-e952-701a-fe292f54886e"},"effectiveDateTime":"2019-05-27T13:52:21-04:00","reasonReference":[{"reference":"Condition/6b4b8e77-da6a-0a3a-908d-7e68997b0e82","display":"Malignant neoplasm of breast (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e39f4470-6ed2-020b-643e-81a22f8a9c9e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/ab112dd0-bb0e-42f8-1366-254f00499b6b"},"context":{"reference":"Encounter/c74b2074-2823-3cc1-0a5c-eb3df5dd173d"},"effectiveDateTime":"2021-03-30T15:23:19-04:00"}
{"resourceType":"MedicationAdministration","id":"45dc3dc4-c5cb-52d3-4d3c-71b276eab981","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/92602ee6-6d2f-fcd8-1644-4188ad93109c"},"context":{"reference":"Encounter/60a25385-e828-382e-022e-7bb5c6669188"},"effectiveDateTime":"2014-01-31T17:49:43-05:00"}
{"resourceType":"MedicationAdministration","id":"bf95d88b-31bf-843d-bd69-fb69eb8ca2f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/c7b26e8b-82dd-77df-f965-c24fc599e19b"},"context":{"reference":"Encounter/23b4280a-c726-ac30-ba4f-7bbf9fc435d3"},"effectiveDateTime":"2020-01-16T16:19:28-05:00"}
{"resourceType":"MedicationAdministration","id":"1d139320-083c-ff23-4a0d-85f94d36b3b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/f7931d69-5d99-9f74-47cc-55f26e7220da"},"context":{"reference":"Encounter/3154d6a5-973e-80b5-06db-c2e14d88d3b2"},"effectiveDateTime":"2007-06-30T16:51:50-04:00"}
{"resourceType":"MedicationAdministration","id":"7bfc8f89-f0d9-f67d-d784-0d2a1f5799bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/fce0bce5-af05-ce03-b87b-6606dde7466e"},"context":{"reference":"Encounter/beae5005-5000-3f4c-61c1-1612a2ab46c2"},"effectiveDateTime":"2018-01-24T16:12:08-05:00"}
{"resourceType":"MedicationAdministration","id":"fbb31fa2-71c0-39b2-68d7-f5bde1873af1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/f7931d69-5d99-9f74-47cc-55f26e7220da"},"context":{"reference":"Encounter/b839b59b-f266-563d-87d3-1a6ca58f5b66"},"effectiveDateTime":"2010-06-14T17:11:30-04:00"}
{"resourceType":"MedicationAdministration","id":"15762c9e-a38b-9a3b-0bf6-e6cba63f5e79","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"200064","display":"letrozole 2.5 MG Oral Tablet"}],"text":"letrozole 2.5 MG Oral Tablet"},"subject":{"reference":"Patient/fce0bce5-af05-ce03-b87b-6606dde7466e"},"context":{"reference":"Encounter/81906c41-bf52-1d42-824a-db2548a3999e"},"effectiveDateTime":"2019-12-02T11:29:33-05:00","reasonReference":[{"reference":"Condition/ed86c23c-62b1-65a2-6122-7a9d77c08c1d","display":"Malignant neoplasm of breast (disorder)"}],"dosage":{"dose":{"value":1}}}
{"resourceType":"MedicationAdministration","id":"3387e313-b4bb-4d06-012a-6702139c1397","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1860480","display":"1 ML DOCEtaxel 20 MG/ML Injection"}],"text":"1 ML DOCEtaxel 20 MG/ML Injection"},"subject":{"reference":"Patient/c3901a6c-c7d0-2eae-0d42-8f1d6e79feaf"},"context":{"reference":"Encounter/439d9573-0659-979e-d604-2fbc9a147dbc"},"effectiveDateTime":"2015-06-30T15:33:30-04:00","reasonReference":[{"reference":"Condition/1e6fe881-3663-4f9d-0aee-8820c2574a8e","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"f37b884e-60a7-3e47-f9b0-16bb74c6b13e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"752899","display":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"}],"text":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c3901a6c-c7d0-2eae-0d42-8f1d6e79feaf"},"context":{"reference":"Encounter/439d9573-0659-979e-d604-2fbc9a147dbc"},"effectiveDateTime":"2015-06-30T15:33:30-04:00","reasonReference":[{"reference":"Condition/1e6fe881-3663-4f9d-0aee-8820c2574a8e","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"7de19041-06bf-9183-c182-1eae1adf12fe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1860480","display":"1 ML DOCEtaxel 20 MG/ML Injection"}],"text":"1 ML DOCEtaxel 20 MG/ML Injection"},"subject":{"reference":"Patient/c3901a6c-c7d0-2eae-0d42-8f1d6e79feaf"},"context":{"reference":"Encounter/08563a83-e706-b0e7-bf62-f411e16d0ff5"},"effectiveDateTime":"2015-09-28T20:25:30-04:00","reasonReference":[{"reference":"Condition/1e6fe881-3663-4f9d-0aee-8820c2574a8e","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"39d7fe76-b151-d17c-da5e-6b8ad0d34cbf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"752899","display":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"}],"text":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c3901a6c-c7d0-2eae-0d42-8f1d6e79feaf"},"context":{"reference":"Encounter/08563a83-e706-b0e7-bf62-f411e16d0ff5"},"effectiveDateTime":"2015-09-28T20:25:30-04:00","reasonReference":[{"reference":"Condition/1e6fe881-3663-4f9d-0aee-8820c2574a8e","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"11842a90-1957-d20a-91c5-4774f6546225","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1856546","display":"Kyleena 19.5 MG Intrauterine System"}],"text":"Kyleena 19.5 MG Intrauterine System"},"subject":{"reference":"Patient/8af638a2-27f9-5d36-fce9-688fbf066654"},"context":{"reference":"Encounter/434924c1-898a-7cb8-b5e9-48fc9f56ccd9"},"effectiveDateTime":"2019-06-23T21:10:33-04:00"}
{"resourceType":"MedicationAdministration","id":"72f89b59-4423-f411-6837-654b1e3c3a24","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T10:42:28-04:00"}
{"resourceType":"MedicationAdministration","id":"c36d03a5-390a-c4f6-8d5e-ddbd7f1dba35","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659263","display":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"}],"text":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T10:42:28-04:00"}
{"resourceType":"MedicationAdministration","id":"47e795af-16b6-d0da-e701-373377e624c6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1796676","display":"25 ML protamine sulfate (USP) 10 MG/ML Injection"}],"text":"25 ML protamine sulfate (USP) 10 MG/ML Injection"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T10:42:28-04:00"}
{"resourceType":"MedicationAdministration","id":"b0059319-4064-26b9-47af-8ee70f34e8ea","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311034","display":"insulin, regular, human 100 UNT/ML Injectable Solution"}],"text":"insulin, regular, human 100 UNT/ML Injectable Solution"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T10:45:28-04:00"}
{"resourceType":"MedicationAdministration","id":"82a75010-a345-a051-44d7-e7bb1d153f22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1740467","display":"2 ML Ondansetron 2 MG/ML Injection"}],"text":"2 ML Ondansetron 2 MG/ML Injection"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T11:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"7c684f44-8a6e-f966-f70f-ec3e777b1c6f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311700","display":"Midazolam 1 MG/ML Injectable Solution"}],"text":"Midazolam 1 MG/ML Injectable Solution"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T11:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"295b46e7-0612-e3e0-9d42-fb179238ce7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1808217","display":"100 ML Propofol 10 MG/ML Injection"}],"text":"100 ML Propofol 10 MG/ML Injection"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T11:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"0dfbb1c6-ae95-2c87-1f80-6f1a7d12130d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1234995","display":"Rocuronium bromide 10 MG/ML Injectable Solution"}],"text":"Rocuronium bromide 10 MG/ML Injectable Solution"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T11:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"f75377e7-9d37-031f-cc90-5fb605981b6b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"542347","display":"isoflurane 99.9 % Inhalation Solution"}],"text":"isoflurane 99.9 % Inhalation Solution"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T11:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"670d4f79-75d6-a187-7f59-24b65da509e8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1729584","display":"remifentanil 2 MG Injection"}],"text":"remifentanil 2 MG Injection"},"subject":{"reference":"Patient/f7ccc972-7a4f-9d3f-4c16-6628f920f336"},"context":{"reference":"Encounter/27271e2f-8895-a90f-7821-96c6f0aeafd8"},"effectiveDateTime":"2016-06-18T11:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"c10b332b-ee33-8f1c-a761-e9a9c91baae6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"312617","display":"predniSONE 5 MG Oral Tablet"}],"text":"predniSONE 5 MG Oral Tablet"},"subject":{"reference":"Patient/ad442262-e973-d5b6-93df-7f2930f7c052"},"context":{"reference":"Encounter/66c1c5b5-7330-9297-205c-cbd969e3b765"},"effectiveDateTime":"2017-11-02T20:22:54-04:00"}
{"resourceType":"MedicationAdministration","id":"18a1ec93-1477-75d1-4766-f6a6ef35aa6d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-09T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"654ae6f7-6497-f646-0688-92daae5ae297","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-09T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"f1d5fb21-9171-8cc9-05b0-b9562da051d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-09T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"7a53806d-55c0-82f9-1ad0-a2e25fade214","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-10T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"f21ad56d-994e-ee09-df79-f00e16716313","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-10T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"1d28aeaf-0739-b4c8-6c93-a7840b22c8f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-10T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"f5abc091-1f14-d448-4516-b968b62be871","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-11T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"ca5a68a4-1f82-148f-0cd5-c06adc3acd2d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-11T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"0cf131d1-4eea-f5ca-cb27-179713f509a4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-11T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"f99fff5f-ee91-9956-14e5-4802639b86b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-12T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"1b60d05d-48d5-e830-60a9-72d252c3474b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-12T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"d7e7ca45-9478-d035-42e0-a46fd98cf885","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-12T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"3e98c36e-1c4d-90f2-3775-80e13075e05d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-13T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"dc3624cb-954f-2bc6-99a9-38f3e4ba24a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-13T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"eedee66b-f9f4-689d-63e8-d3cb158c1700","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-13T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"cc477a5d-11f1-d480-09f3-5dda54762522","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-14T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"12ec90ea-725b-fff4-e714-d5f48636be2b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-14T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"1d5bb870-7ac7-7a9e-0f1a-59b2a2181974","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-14T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"6d91bc0a-6085-4196-0bb9-0ca93677055e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-15T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"61335505-0f86-edf6-4e92-714189696300","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-15T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"e4711c55-76bb-20de-26f6-130504d95dd0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-15T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"70374682-eebc-5f9b-1179-c1dab5e01784","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-16T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"0851c8ea-e1c8-e6aa-2611-0df4f5a3a4e3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-16T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"88994463-e43c-7544-16e0-b43526c16bf4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-16T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"0b4ddd5f-587f-1108-1f75-92dbcc042692","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854252","display":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"}],"text":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-17T08:17:20-05:00","reasonReference":[{"reference":"Condition/daf71a4b-956a-afb2-0d10-43508e033e82","display":"Acute pulmonary embolism (disorder)"}],"dosage":{"dose":{"value":1},"rateQuantity":{"value":2}}}
{"resourceType":"MedicationAdministration","id":"dde2f25a-aee6-70bf-89c6-8e835b3711fd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-17T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"9a9004ca-a1ff-60bf-a4bb-18f2f16a59a6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-17T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"c192bbf8-7cc7-84f4-73ba-0c9752b9582f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854252","display":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"}],"text":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-18T08:17:20-05:00","reasonReference":[{"reference":"Condition/daf71a4b-956a-afb2-0d10-43508e033e82","display":"Acute pulmonary embolism (disorder)"}],"dosage":{"dose":{"value":1},"rateQuantity":{"value":2}}}
{"resourceType":"MedicationAdministration","id":"4e2679a8-8a32-d805-b277-1ae636167e7a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-18T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"dacdfe71-678a-0c91-021e-9d47595d4744","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-18T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"6fe784ca-686c-fbc8-a06e-98f2b7d7f4b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854252","display":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"}],"text":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-19T08:17:20-05:00","reasonReference":[{"reference":"Condition/daf71a4b-956a-afb2-0d10-43508e033e82","display":"Acute pulmonary embolism (disorder)"}],"dosage":{"dose":{"value":1},"rateQuantity":{"value":2}}}
{"resourceType":"MedicationAdministration","id":"7d8eba91-f3ea-ee1c-6aed-d81804cd6326","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-19T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"0aebeba4-acf1-4137-cff5-ff7f6b2c4d58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-19T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"54b4d86b-ee9d-6f29-728d-4f0e63a75c88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854252","display":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"}],"text":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-20T08:17:20-05:00","reasonReference":[{"reference":"Condition/daf71a4b-956a-afb2-0d10-43508e033e82","display":"Acute pulmonary embolism (disorder)"}],"dosage":{"dose":{"value":1},"rateQuantity":{"value":2}}}
{"resourceType":"MedicationAdministration","id":"102a1ece-19ab-d5c9-bfb9-0b096aee5abf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-20T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"fb212b75-c4b8-cce9-0efb-e9b175a611f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-20T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"15b665aa-aff7-b004-910e-2d3567105146","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854252","display":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"}],"text":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-21T08:17:20-05:00","reasonReference":[{"reference":"Condition/daf71a4b-956a-afb2-0d10-43508e033e82","display":"Acute pulmonary embolism (disorder)"}],"dosage":{"dose":{"value":1},"rateQuantity":{"value":2}}}
{"resourceType":"MedicationAdministration","id":"ab22483f-ed1e-e81d-e778-0104f732c2db","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-21T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"d97c4d25-73f6-a9c1-7852-3f0821bcd112","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-21T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"6d52b2c2-b5bc-42d9-5526-d4ea065b18cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854252","display":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"}],"text":"1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-22T08:17:20-05:00","reasonReference":[{"reference":"Condition/daf71a4b-956a-afb2-0d10-43508e033e82","display":"Acute pulmonary embolism (disorder)"}],"dosage":{"dose":{"value":1},"rateQuantity":{"value":2}}}
{"resourceType":"MedicationAdministration","id":"ba1dd7be-22d8-d10b-2516-cba833ecf95b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2123111","display":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"}],"text":"NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-22T08:17:20-05:00","reasonReference":[{"reference":"Condition/d1025fda-6352-4a66-1bce-aa3271bd1ff6","display":"Hypoxemia (disorder)"}],"dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"0b0461bf-e850-f968-1f2c-173c624601f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/513cbef7-5276-9d17-97d2-bea826566ddf"},"context":{"reference":"Encounter/184e4df2-9dd3-91e4-5605-b013bd3bb68e"},"effectiveDateTime":"2021-01-22T08:17:20-05:00"}
{"resourceType":"MedicationAdministration","id":"c4e664d6-712d-30cc-b6b1-1bf4e6f555f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/8391a87b-421b-1184-7a03-7189b8a4648b"},"context":{"reference":"Encounter/d5bf171f-8aa2-653d-a9db-bbdc276eb2e4"},"effectiveDateTime":"2014-04-10T19:54:07-04:00"}
{"resourceType":"MedicationAdministration","id":"c2ecb435-c7c6-b760-1d5c-0fc903305f0d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/904a881f-3c45-302b-b692-dc44657c0cd5"},"context":{"reference":"Encounter/783f5620-f905-4746-80fc-77e57a4dd015"},"effectiveDateTime":"2013-11-21T11:02:27-05:00"}
{"resourceType":"MedicationAdministration","id":"1293c016-c1d7-4045-4bd2-39991a453b3d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/1c62850c-48d2-3bce-5951-57fc06c1d956"},"context":{"reference":"Encounter/5ee7da6c-db65-3088-c3aa-8b54ee275326"},"effectiveDateTime":"2013-08-27T06:51:53-04:00"}
{"resourceType":"MedicationAdministration","id":"fe174bd1-e7c4-3de6-f730-ea327ddfbda3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/1c62850c-48d2-3bce-5951-57fc06c1d956"},"context":{"reference":"Encounter/c6ae977d-cb1f-593a-da89-cd5df89b4157"},"effectiveDateTime":"2015-10-28T06:51:53-04:00"}
{"resourceType":"MedicationAdministration","id":"d9d4c869-ad14-d44b-c295-f4a0ad768823","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/1c62850c-48d2-3bce-5951-57fc06c1d956"},"context":{"reference":"Encounter/8ed2c497-af71-6b24-5253-e429fd91d2a4"},"effectiveDateTime":"2016-10-22T07:22:13-04:00"}
{"resourceType":"MedicationAdministration","id":"f10f5816-a1c1-fbd2-1d46-5b2f9483de94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/1c62850c-48d2-3bce-5951-57fc06c1d956"},"context":{"reference":"Encounter/9b1e8fd9-c5a2-5de5-c76d-d2888e77ba4f"},"effectiveDateTime":"2019-10-07T08:00:39-04:00"}
{"resourceType":"MedicationAdministration","id":"315d3f13-e1e0-0ef4-fe9b-3c8c267fed64","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/13175021-79cd-6187-fea8-2722363ba6d2"},"context":{"reference":"Encounter/0bce78f7-dcfd-1d21-210b-62f8fa69720a"},"effectiveDateTime":"2013-11-01T13:41:19-04:00"}
{"resourceType":"MedicationAdministration","id":"00bd1401-6a43-0b34-159a-de85dd928a92","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/13175021-79cd-6187-fea8-2722363ba6d2"},"context":{"reference":"Encounter/753f56ae-ceba-7af9-6e9c-e12c9ed4ce13"},"effectiveDateTime":"2021-11-30T12:41:19-05:00"}
{"resourceType":"MedicationAdministration","id":"99e97452-7f46-ce2c-b937-0f5bdad8c258","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/2836448b-37bb-a0fd-eb97-9dd30c923181"},"context":{"reference":"Encounter/3dcd7397-3076-ae44-9985-39be5d2f436f"},"effectiveDateTime":"2015-01-25T02:48:29-05:00"}
{"resourceType":"MedicationAdministration","id":"9b225c68-778b-2fd7-0ea3-0ce5adfeab9e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/2836448b-37bb-a0fd-eb97-9dd30c923181"},"context":{"reference":"Encounter/e9a1394e-3cea-f243-9dae-7fcd0861c196"},"effectiveDateTime":"2016-01-24T20:31:39-05:00"}
{"resourceType":"MedicationAdministration","id":"cb841d6a-1570-d44f-4ac3-56cd3716c06a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/06f1f7c8-81c7-36e8-1a29-13d0c09ee0bc"},"context":{"reference":"Encounter/ff615945-3f64-5669-2763-0dfb39d28e5f"},"effectiveDateTime":"2021-03-03T19:19:11-05:00"}
{"resourceType":"MedicationAdministration","id":"b2ec774d-6cde-71d2-50a2-e9dada429d15","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/fd21b102-9cef-7e48-d216-b0cade001de3"},"context":{"reference":"Encounter/c5334dc2-cb14-85bd-10f2-f3f723e19f2c"},"effectiveDateTime":"2015-07-02T18:11:30-04:00"}
{"resourceType":"MedicationAdministration","id":"98d68414-b0b0-9a44-0477-de29abe126a6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/fd21b102-9cef-7e48-d216-b0cade001de3"},"context":{"reference":"Encounter/798a9c26-30fc-635e-580c-365d8c941071"},"effectiveDateTime":"2019-03-04T17:11:30-05:00"}
{"resourceType":"MedicationAdministration","id":"2935a2d3-a356-3d3d-44dc-d91657803adc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/fd21b102-9cef-7e48-d216-b0cade001de3"},"context":{"reference":"Encounter/ccea1261-41d5-b7e1-73b9-832e90b6627d"},"effectiveDateTime":"2020-02-27T17:30:38-05:00"}
{"resourceType":"MedicationAdministration","id":"c8f4bac6-0e51-3af3-cfbb-71dddefe4576","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/fd21b102-9cef-7e48-d216-b0cade001de3"},"context":{"reference":"Encounter/1b94e6ae-65f7-585f-2d3a-c60c67e5275c"},"effectiveDateTime":"2022-02-16T18:01:43-05:00"}
{"resourceType":"MedicationAdministration","id":"23b27e3a-555e-06a2-8c06-a4ec9607d527","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/fd21b102-9cef-7e48-d216-b0cade001de3"},"context":{"reference":"Encounter/d3f78992-3b6f-a6ea-e86a-a079c2a29259"},"effectiveDateTime":"2023-02-11T18:23:40-05:00"}
{"resourceType":"MedicationAdministration","id":"7f270e4b-47f5-de82-033b-93df9c7d55cc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T21:59:04-04:00"}
{"resourceType":"MedicationAdministration","id":"5a7c90cc-fa2d-349f-e1f3-da510eb2c8f3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659263","display":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"}],"text":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T21:59:04-04:00"}
{"resourceType":"MedicationAdministration","id":"1067a705-f72c-fc60-a4bc-2e7d40b110e5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1796676","display":"25 ML protamine sulfate (USP) 10 MG/ML Injection"}],"text":"25 ML protamine sulfate (USP) 10 MG/ML Injection"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T21:59:04-04:00"}
{"resourceType":"MedicationAdministration","id":"bf350345-904b-d511-d37f-0d885a761911","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1740467","display":"2 ML Ondansetron 2 MG/ML Injection"}],"text":"2 ML Ondansetron 2 MG/ML Injection"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T23:13:49-04:00"}
{"resourceType":"MedicationAdministration","id":"98608573-6501-294a-1863-0eb4ad5a6e93","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311700","display":"Midazolam 1 MG/ML Injectable Solution"}],"text":"Midazolam 1 MG/ML Injectable Solution"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T23:13:49-04:00"}
{"resourceType":"MedicationAdministration","id":"201ece69-3f1d-3e5d-74a6-ce91d331c3f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1808217","display":"100 ML Propofol 10 MG/ML Injection"}],"text":"100 ML Propofol 10 MG/ML Injection"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T23:13:49-04:00"}
{"resourceType":"MedicationAdministration","id":"c07312b5-75cb-3d31-c1b7-b359a26de171","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1234995","display":"Rocuronium bromide 10 MG/ML Injectable Solution"}],"text":"Rocuronium bromide 10 MG/ML Injectable Solution"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T23:13:49-04:00"}
{"resourceType":"MedicationAdministration","id":"8ed8ba3c-40f2-0560-a15b-4aeecb830565","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"542347","display":"isoflurane 99.9 % Inhalation Solution"}],"text":"isoflurane 99.9 % Inhalation Solution"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T23:13:49-04:00"}
{"resourceType":"MedicationAdministration","id":"4f18e95a-ad00-d0f1-619b-7a0d3791d0f6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1735006","display":"10 ML Fentanyl 0.05 MG/ML Injection"}],"text":"10 ML Fentanyl 0.05 MG/ML Injection"},"subject":{"reference":"Patient/e762c521-f81e-f2b3-0fa2-264661fff724"},"context":{"reference":"Encounter/672067d3-27fd-f575-aada-fa78b495f7bd"},"effectiveDateTime":"2018-09-29T23:13:49-04:00"}
{"resourceType":"MedicationAdministration","id":"84200702-2101-6045-7b2e-491795692371","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/fc883da0-5629-d734-6dfe-196eff872bfc"},"effectiveDateTime":"2013-06-20T03:45:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1b86134-b876-6452-897b-8d2bc6f87664","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a2732144-2247-e5f3-a038-0e26d9d2b0d8"},"effectiveDateTime":"2013-06-23T06:18:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"de7e6022-4741-153b-fc03-349c16c76d29","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e7cf1025-a166-bba2-1426-04093acfb841"},"effectiveDateTime":"2013-06-26T09:16:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0fafd28e-9f57-d81f-139a-7a5e25afc63d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9c81190d-051d-422c-161f-1167fcd2b4c9"},"effectiveDateTime":"2013-06-29T11:18:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"91614e0d-1635-ddff-61f0-19e70700dbc3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/28fff2cf-3be3-6a70-f899-8fccd4e9cd50"},"effectiveDateTime":"2013-07-02T14:11:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a34afc6-84be-e4d1-0a8d-f8e3fd2463b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f7d3a60e-6b3b-3ff2-ce61-dc594fb6ee06"},"effectiveDateTime":"2013-07-05T17:24:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a62d62e7-4a43-ce01-801e-2de50e34a285","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3c9ca6d6-f471-e21a-bbed-049a710ebe49"},"effectiveDateTime":"2013-07-08T20:35:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c42803d-59fd-51ef-3f82-87251d2948ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b7a7294f-a84d-1189-445d-b91c355aa3d2"},"effectiveDateTime":"2013-07-11T23:04:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea8e838b-7154-0280-94bb-fbf0f0360ae7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d7071698-e2f7-a0bd-4ce9-61988bbd4a54"},"effectiveDateTime":"2013-07-15T01:35:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d4e82f4-b964-017e-080b-fb5a384611ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/047ab207-5752-8187-6c4c-febd2f407e4c"},"effectiveDateTime":"2013-07-18T05:06:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"65da225e-bb80-7f33-42a2-0da907b85520","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/90b8d9e3-ee11-3f34-a8c1-c0828f11e409"},"context":{"reference":"Encounter/f0407168-5380-e7ba-2537-0536df28e09b"},"effectiveDateTime":"2013-08-10T01:42:52-04:00"}
{"resourceType":"MedicationAdministration","id":"a52ddb3c-9178-a2b2-5f1e-a63a55a9d3f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/806620c3-7964-44db-5d21-b1c614a43d1a"},"effectiveDateTime":"2013-07-21T08:32:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5a095d8f-843b-959b-5d9c-c552b032a6a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d53f6da5-dcf1-ae28-3eb0-974f746406d2"},"effectiveDateTime":"2013-07-24T11:23:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3b3fcb00-94a7-b734-8057-3aac33b46710","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d4c1a941-b70f-2cff-c420-32ce77a55a29"},"effectiveDateTime":"2013-07-27T14:56:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cca6c728-be7d-fc91-dcee-96af166c1f9d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/4d88625b-115c-db18-9f8a-1c166f61630d"},"effectiveDateTime":"2013-07-30T17:42:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c2bad48-91e8-faa1-09ed-612a27e48384","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9920a082-bd1d-90cb-1fd3-73d72938dd42"},"effectiveDateTime":"2013-08-02T19:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b768fb1-7928-2f29-0ba1-aee4b7418ee2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d25d664c-ab7d-6831-a265-a22fa43eeec3"},"effectiveDateTime":"2013-08-05T22:05:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89815523-61c4-e986-c456-4f142cc2ae17","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e1c6ce77-26f1-5e26-a846-8aa1852e93bc"},"effectiveDateTime":"2013-08-09T00:06:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a6bdf6d0-9c23-8726-8308-0d5b73c293d6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/27914725-f119-e1bb-56b0-fddbea8616ab"},"effectiveDateTime":"2013-08-12T03:30:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47da3729-78ed-7ade-de0a-8360b706da96","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/053f97d4-b85c-beb0-3f99-ce5a9a6a9780"},"effectiveDateTime":"2013-08-15T06:32:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e5cf4dfb-a87d-302d-e159-5500acb111c3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b4faad9d-9b03-b9e1-cba5-87e2c981c6ef"},"effectiveDateTime":"2013-08-31T04:41:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a127ea7a-3aa0-1ea9-594a-1772a01f0133","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9c078c35-886d-80f3-9ea2-3acefb38663d"},"effectiveDateTime":"2013-09-03T06:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"70bccf2c-474b-70fd-43a5-9eb29f399a18","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/30a2e44a-7517-2a69-aa57-4018ec473a3e"},"effectiveDateTime":"2013-09-06T09:05:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5686025c-1a7f-209b-15f7-4f4196cd9cce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2d8ff647-ea32-0fdc-e609-87b6c2afc9bc"},"effectiveDateTime":"2013-09-09T12:44:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cc354a7a-f6a6-91da-bb60-97735c25747c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/15987921-6dc8-e543-7124-16c35d9f8d3c"},"effectiveDateTime":"2013-09-12T16:37:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"94b7d01b-f928-62f6-33c4-7ff84e64e9ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e85d5f12-4cef-8fa9-907f-d1d5259345e5"},"effectiveDateTime":"2013-09-15T18:47:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67d1b19f-2a0c-9684-2fb6-ee530ba2920f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d5e88703-c194-f35b-ebdc-5a559cdac730"},"effectiveDateTime":"2013-09-18T22:07:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b02baf8d-157b-a783-6839-ad270646a549","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/cca9339c-ff8f-b88c-c2ed-364a866639fc"},"effectiveDateTime":"2013-10-05T06:05:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d83d3d5b-0f13-004e-eff1-1ef10a9e9080","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/dab40dc1-10f8-9704-86fe-beab735cbe6d"},"effectiveDateTime":"2013-10-08T08:51:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6623bc81-e1bd-55f1-51c2-c931be1ada6e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/bbfc034e-287a-a59b-157d-c916938ffd12"},"effectiveDateTime":"2013-10-11T12:16:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"57019467-9f92-565b-ce0f-33744f6eb4e0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/151b64fd-6152-93e9-9fc7-26b117b7a554"},"effectiveDateTime":"2013-10-14T15:07:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1538b9f3-492f-7656-2e98-72b25108c594","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/95924396-07ee-51b5-07c1-218bc33eacfe"},"effectiveDateTime":"2013-10-17T17:14:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5321526-5c81-4d5b-f2f0-2f17277f13a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/543dd7cf-fe60-859a-b0f1-7c3fde334d68"},"effectiveDateTime":"2013-11-02T05:45:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"800b1626-f2a1-9ff4-a2de-7017bd9f664c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b7a4bfea-c88c-d0a2-7b30-35c9286abb4a"},"effectiveDateTime":"2013-11-05T07:07:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"103c46d0-a42f-782c-6ff5-13d3dbdab645","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e941f30d-0452-7116-ba08-eecd6c90a3bd"},"effectiveDateTime":"2013-11-08T09:31:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77b18579-5916-14a6-46b6-01a0972f745f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/ad98fa03-8e09-5017-4eb7-cbee3a5267e6"},"effectiveDateTime":"2013-11-11T12:16:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e2a29525-df3f-1989-45c1-6f16aa3ce012","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/eaefe36c-fc7f-49f2-c19a-393f1d62590d"},"effectiveDateTime":"2013-11-14T15:59:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"133d3ae5-dc73-1abc-bd71-1c7bd800cb4f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/10294a7e-e8d1-af28-0537-76b8b69f5631"},"effectiveDateTime":"2013-11-30T04:21:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f85ba51d-6e77-dc8f-17a6-9b99a1374e4a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/64d52e50-9ff8-d34f-44f4-888b59dae9fa"},"effectiveDateTime":"2013-12-03T07:51:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14bf37e3-d11f-f15b-19f3-1979ccade2bc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/92a81d12-7f10-9820-944a-7c819d2a6eec"},"effectiveDateTime":"2013-12-06T11:21:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f734904-8ee7-77f1-8f2c-2a1b513ab60a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8b2139e7-2909-463f-f107-5e31ca21e489"},"effectiveDateTime":"2013-12-09T14:01:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78877e19-591f-55f5-5ba3-c0e49738b5ae","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/37174104-3dcc-f2d2-6b28-205501263f9b"},"effectiveDateTime":"2013-12-12T17:23:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"901f3250-d6fd-335a-8bad-845368b114f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3fe90739-4c5f-d5db-1063-34dbc97f2ced"},"effectiveDateTime":"2013-12-15T20:31:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86841a8e-9d0a-b411-4f5c-035e2362a24b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9fb70f72-0713-39c8-80ac-2650d0440d7e"},"effectiveDateTime":"2013-12-18T23:33:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c8755b05-48d5-ebd2-58cd-1499f40339ee","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"312617","display":"predniSONE 5 MG Oral Tablet"}],"text":"predniSONE 5 MG Oral Tablet"},"subject":{"reference":"Patient/38dc06ba-028d-026f-aec1-84efffcf49eb"},"context":{"reference":"Encounter/471d2f47-0735-b410-5f31-a5f41d5a2822"},"effectiveDateTime":"2023-01-02T08:02:04-05:00"}
{"resourceType":"MedicationAdministration","id":"662b7f47-6bdf-c89f-401c-4a45336c3591","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/549eef5c-b598-122f-8b85-ba2285652c10"},"effectiveDateTime":"2014-01-04T03:51:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"206f24a3-a1fd-6839-178d-963311652b65","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2d8d0986-cd49-d346-d20d-576a185bbc86"},"effectiveDateTime":"2014-01-07T06:15:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1b1d327-a019-a927-0974-ff1ebecb7ac9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/cf626107-e7ee-e35b-a658-1c7a70b207d9"},"effectiveDateTime":"2014-01-10T09:07:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fb57e046-8501-cc6f-f7b7-8d63fd674b53","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/88158213-4d05-29b6-7523-ff1e66827746"},"effectiveDateTime":"2014-01-25T04:40:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"92975041-5a5b-f298-b56c-b7a91d87e9b8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a4cf20f4-c45a-c57e-501d-a25625c036f3"},"effectiveDateTime":"2014-01-28T07:03:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"262684da-bf05-91dd-07bc-806af0aeaa91","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2f5e5347-468c-6f97-454e-a1f49cee3de2"},"effectiveDateTime":"2014-01-31T10:11:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b3d3a6d-f16a-d96b-6f71-1c03ecfb2b4f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f17d6ac9-3886-a2fd-4ed5-7e1dae725680"},"effectiveDateTime":"2014-02-03T13:17:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5c06801e-42fd-1651-4022-fff9fff57bd0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3d6f3317-64e1-0650-cfd7-8f8fd6695df0"},"effectiveDateTime":"2014-02-06T16:06:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"52ce82a7-9015-229f-a70b-fb0d0ef9470f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c014105c-a2c1-5fed-12f8-4cd991df357b"},"effectiveDateTime":"2014-02-09T18:06:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"38bd3851-76ff-2048-8571-19e7728fd200","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/540133d5-5252-c79b-495a-b8ad31eceaa5"},"effectiveDateTime":"2014-02-12T20:35:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c1f7934-474e-80da-9187-b93716d4d8c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6410c8d5-417d-9c38-68e1-87cd963a4263"},"effectiveDateTime":"2014-03-01T04:51:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4c9361e-6268-0c7e-43d5-e5faee371f6a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d9660213-7727-c4a9-8edb-987f64fc288b"},"effectiveDateTime":"2014-03-04T07:00:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4d525d98-56d8-9e95-62e5-455b82cfc1c9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/7118724b-0845-cf9e-afd8-6a98c78c09af"},"effectiveDateTime":"2014-03-07T09:56:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0f8c95f5-219d-07f1-33f1-487d096033e8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a53cbcf3-1594-f45c-55d8-6325a2ad5762"},"effectiveDateTime":"2014-03-22T05:50:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a91f7599-7cfb-9334-7f9b-a858ef45da7d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b3ff51e7-b8c1-77d2-735e-4512325de962"},"effectiveDateTime":"2014-03-25T08:07:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"798f20e6-c528-ce5c-42c8-3987ff19995a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c2879011-5d2f-f796-a3c8-07d9dbedecd7"},"effectiveDateTime":"2014-03-28T10:36:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fb6c056a-e3be-80c9-7a50-aa00da2bf92f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5b0bed61-e752-9feb-7cfa-d29064850b61"},"effectiveDateTime":"2014-03-31T13:31:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"397d6ede-12be-721e-e365-320a09e3d7ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a299df6b-48a4-0a36-ae2a-2ddaf05c15e0"},"effectiveDateTime":"2014-04-03T17:14:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00042a8e-15f0-c370-698a-de0806bbc139","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/577f4bba-56aa-827a-5182-8a6a73c5c8b1"},"effectiveDateTime":"2014-04-06T20:18:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df8be759-27ce-dfdf-9efe-45bb88e55c12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c1d02d91-545f-2dd1-d5e7-0ed105b2ba0e"},"effectiveDateTime":"2014-04-09T22:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2a02302e-0ee4-ae56-4361-e95f48e74d94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/0ae2dc11-2271-0a5e-9b7e-1e00b8bf7b54"},"effectiveDateTime":"2014-04-13T02:46:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f5d3b60-b7ae-76c8-c33e-d15c4ae2086f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b6f8a13c-d57a-c70b-1ba7-4943335ecc2e"},"effectiveDateTime":"2014-04-16T05:12:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4a94f9b-ac43-f522-6fa7-198d0a5b6f13","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/324cff3b-6d23-f158-d4e6-222a55c8d81f"},"effectiveDateTime":"2014-05-03T05:22:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d29f6192-3dec-b877-40a0-c95569e3e07e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/31309042-6092-304c-ec98-7b8d474414cf"},"effectiveDateTime":"2014-05-06T09:03:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0afb5bff-253a-bb23-17ab-38a0417864c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a0accf3b-6fde-a01b-ff5e-ec1692d6ede0"},"effectiveDateTime":"2014-05-09T12:21:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8193b885-33bd-189c-7f5d-da800e970967","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/90356004-b54a-4d20-2a64-58cf69dc83bc"},"effectiveDateTime":"2014-05-12T15:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b3bcb279-052b-0938-7dee-e628df1bd436","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5d7bbb33-09f4-728d-159f-f3aaab72004d"},"effectiveDateTime":"2014-05-15T19:31:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9670054d-1352-99df-d8b2-6ce7041d97a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/06b9a238-59bb-65b5-6f5f-e8f2e88c7bf1"},"effectiveDateTime":"2014-05-18T22:21:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26e378d9-8ac3-7aaa-c162-b6f2ea7cc4f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/afe04007-5c4e-e4f6-8021-35b368f12da4"},"effectiveDateTime":"2014-05-22T01:50:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4cc76e97-fc7d-2f85-485c-33bc5ff1111b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8a78de0d-8c2a-3210-5097-95ed3c359741"},"effectiveDateTime":"2014-05-25T04:56:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e0260231-2a5f-205b-9f98-9ed71acd9c8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/7942144f-ace3-66c6-308d-bdd4f9dd8c91"},"effectiveDateTime":"2014-05-28T07:36:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"819e2600-b48c-dd7e-ad95-500bf6e7c541","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6322072f-8ed4-baf7-1eeb-6d0402dca571"},"effectiveDateTime":"2014-05-31T11:12:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0984a123-6748-c8a4-39b4-d2c273f8a54d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b9841ccf-0a19-d858-3382-73aa4bd26156"},"effectiveDateTime":"2014-06-03T14:41:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd5775e0-2f52-7bdc-4139-0bdbc498be73","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/fec3ffac-fc2a-f040-e288-c822df8620cc"},"effectiveDateTime":"2014-06-06T17:48:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"db9312e9-b8be-80ac-5a78-6c931f5bf912","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5775651f-7324-a70d-b5b4-b9d142791ad4"},"effectiveDateTime":"2014-06-09T21:16:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86ff5169-f57f-f056-ff64-d04f57430253","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5f3c0c4e-92c6-34d1-350b-37a9e1a6f127"},"effectiveDateTime":"2014-06-13T00:46:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"18813d23-a0f1-7723-2531-19d4bee9aec2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/94ab44d8-2a39-5ec7-323a-cd1d4b3fd3ea"},"effectiveDateTime":"2014-06-28T05:54:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"497d4a0e-1674-721a-6ba2-73c8073f6fe5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6ad7fbbd-c2ea-31b5-5e0f-b9da6e182763"},"effectiveDateTime":"2014-07-01T09:44:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e08c0fc-ab01-63c0-7535-8920126926ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/42cc5ed3-906a-4b9e-d655-97886bf3e291"},"effectiveDateTime":"2014-07-04T11:47:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"79d7d913-4915-3be5-b7f1-38ccb15cdf44","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e85956f5-c254-689b-d2ac-f72458f4b3cd"},"effectiveDateTime":"2014-07-07T15:18:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b2fdafe9-3de8-7cd0-dff6-15682391a997","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6922dd8b-fe6f-5575-df28-de14f3462dcb"},"effectiveDateTime":"2014-07-10T18:23:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86b289e3-2264-31b3-5f55-4df99e96f126","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8408c8d9-b788-67e7-eed6-1c3370c4eec5"},"effectiveDateTime":"2014-07-13T21:51:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4fe9f1d-2aeb-43a2-d9e7-1c910c813f39","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b1f98182-ef0c-f82b-8c96-ff6bb7905f17"},"effectiveDateTime":"2014-07-17T00:00:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f1588b5-36fd-60d7-9643-92f455e52403","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/ecf78899-3b23-cab7-a6a1-c732867a044d"},"effectiveDateTime":"2014-07-20T03:04:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bbe7bb1f-80de-905a-2ecc-6125375ac31a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/ef595b07-c0a3-f3a9-43cf-a200eba0710b"},"effectiveDateTime":"2014-07-23T05:47:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"db95eee9-bd1e-fff4-5a7b-c034e70bf85a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/bd2078e8-502c-881c-d2b7-793cc71ddecb"},"effectiveDateTime":"2014-07-26T08:19:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a52e239f-bf92-3fc4-3f1e-ee9d8b45021c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/89e33aed-5e76-d06d-c2e4-fa99f4822f82"},"effectiveDateTime":"2014-07-29T11:41:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a62e0437-83e0-3340-e01e-cf354fa30190","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3ce25990-fab0-d89d-3712-047fde967e05"},"effectiveDateTime":"2014-08-01T14:28:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d9ca331d-2ad0-fd6a-7f35-86d10c66f902","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/7354bc76-cb36-514f-0089-a9a2216c8f67"},"effectiveDateTime":"2014-08-04T16:35:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bb1c701f-2d19-ca57-8077-6c930eafc5ef","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6358ba84-f730-b481-9d9b-2b060b5dda62"},"effectiveDateTime":"2014-08-07T19:00:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d1919470-86d7-56f9-ba9b-337d36b41628","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c28da23e-519b-294b-72a0-e42607ebbc66"},"effectiveDateTime":"2014-08-10T22:45:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d208835-65fc-54bd-004c-7f6572df7fa5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6f9cbc37-4aad-8540-bcd3-672ca3d4cb99"},"effectiveDateTime":"2014-08-14T02:40:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd57ecd2-677b-59a0-0139-82cdffa1ee24","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/4d9e4c00-f82e-9b93-0c1c-41f15e512063"},"effectiveDateTime":"2014-08-17T05:33:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1bc8700-f84d-0e14-897f-b2f828da3b0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/056f31ae-2ac2-e5e2-2162-d6c34c0539e9"},"effectiveDateTime":"2014-08-20T08:08:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f42068d-15d2-e079-c287-d7c7069dde45","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/07c933dd-ce00-0459-ebdc-631ec0b45984"},"effectiveDateTime":"2014-08-23T10:36:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd202317-a31f-a425-7cfc-e74abf0b4332","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/dd7b69d3-99ba-ebe3-8a57-5fc0269bb02b"},"effectiveDateTime":"2014-08-26T12:48:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"922523bd-7861-ef86-187d-1220145f0256","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/fe82a876-8c74-9adc-6ca3-02002a1ab639"},"effectiveDateTime":"2014-08-29T16:47:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"749ad61e-0f55-7054-0d62-194603370650","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/568118a1-6bef-a937-f22d-c0c332b68e18"},"effectiveDateTime":"2014-09-01T19:58:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"252ec342-ff92-02bf-bf1f-8e40cc059a52","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/80b1f1a2-94ab-653d-cc3d-ac2ced66bad0"},"effectiveDateTime":"2014-09-04T22:21:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"487c07f1-7930-93e9-d8f1-9e70b749f3a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/63cc4fd9-9736-4fd1-b1e9-d1176182e0ed"},"effectiveDateTime":"2014-09-08T01:18:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"727e87b5-86ac-f654-af76-ed346cf6d4f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/1d888531-e43f-1f35-1f29-be642a1922b8"},"effectiveDateTime":"2014-09-11T04:10:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b22e051d-a2d1-b0f8-9cee-b399d5912421","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/4d0292eb-b95b-21a7-0e71-2a0c5dcb4cf5"},"effectiveDateTime":"2014-09-14T06:24:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77f45e90-5dde-e062-3767-8b7c47f55c95","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/627e62eb-be75-1376-e2f6-07b22214744d"},"effectiveDateTime":"2014-09-17T09:03:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89ce82cc-0c53-1257-6feb-fb318b397434","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/59a0e302-09e6-d93f-521f-0b379c9982cb"},"effectiveDateTime":"2014-09-20T11:48:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"691f5b65-e188-0bda-479b-8e2554bcf3e9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6fd0245f-5a53-03d4-498f-e834db86cf65"},"effectiveDateTime":"2014-09-23T13:54:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f026048d-b4fd-5ce6-e759-93a8b8e52012","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/67bdca25-6d4c-33c1-7f13-3383fc3ea61a"},"effectiveDateTime":"2014-09-26T17:10:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ca2f6c3d-c856-f75b-83cd-e869bb9510bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a4142e61-0338-b295-a824-d5ca829c066d"},"effectiveDateTime":"2014-09-29T20:13:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4f73efd-8b6f-a42c-64d4-0f3f3d5f4339","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/583fec76-b9dc-e903-2402-f7a07868a87d"},"effectiveDateTime":"2014-10-02T23:50:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fa2acf1a-a0e2-d258-be69-9ea0f8d13afb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/267a73ce-a3a5-96c9-de1c-b524a69ffdf6"},"effectiveDateTime":"2014-10-06T03:31:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"499d1d74-09fb-ce67-9b57-0e3f07c8f2d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e5dea54f-fe0e-af62-0306-7e22aec13ad4"},"effectiveDateTime":"2014-10-09T06:32:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c8a8123d-588b-1f05-a2ba-c2251bb7163b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/bb4f1b51-5ced-2374-e62b-fd0c64b35582"},"effectiveDateTime":"2014-10-25T05:02:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2677d624-8907-fbd1-dad1-10155405c957","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/76b45bd1-54a3-5d2a-03a6-04f3cb48976b"},"effectiveDateTime":"2014-10-28T08:28:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"12ff2f91-8f0a-ff51-9ff7-951075d67bdb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5690df87-cc87-1557-397d-741296bf409f"},"effectiveDateTime":"2014-10-31T12:17:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"87881b5f-0969-9496-ffed-9a45dcf20ee3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/cb625c50-5b6f-9f33-8a04-fadbcd7b83d6"},"effectiveDateTime":"2014-11-03T14:17:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e705c9cc-00fd-6008-de3c-a63862e52334","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/11cda8d8-adcc-2e8d-77ee-dbbf454b6d96"},"effectiveDateTime":"2014-11-06T17:02:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5429b113-6e74-027a-c9b1-c6b27b23df56","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b6458fd3-7c8a-90ad-0a2e-1d9d1c6477e1"},"effectiveDateTime":"2014-11-09T20:43:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"571e1ec5-d40b-d911-a5d8-0f90d1d9b077","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/13d7ce05-5e39-c926-d2a8-6f58e6f6be59"},"effectiveDateTime":"2014-11-12T23:32:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"30e0e859-591c-808d-edd4-ccd09735e046","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b049c8b6-75c1-9fca-73a3-41713d3d80ed"},"effectiveDateTime":"2014-11-16T03:08:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cdfaa39b-73fd-34d7-c996-92d9def1166d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d210610e-73e3-dbea-2c5c-be3eac652da9"},"effectiveDateTime":"2014-11-19T05:42:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2edff6db-143e-1818-2cad-fea737d808e3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/53fc7f7a-3dd0-445d-b66d-d283ed1e3dac"},"effectiveDateTime":"2014-11-22T09:05:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"79a5cdde-7ddb-9d9d-b7bf-2d9840d506fc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/75686a34-e2fb-5df9-05f4-e99237642eab"},"effectiveDateTime":"2014-11-25T11:38:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1b4d2113-6567-903b-96c0-a8b272176d1d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d0423437-c8a8-1ec6-c0e0-4f6b55b77f50"},"effectiveDateTime":"2014-11-28T13:50:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9450400b-405d-cf05-ec3e-b1ca18549e8b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a423574e-882b-f7f8-4657-edb1eae04054"},"effectiveDateTime":"2014-12-01T17:03:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c905523-f76f-b17c-1ef3-ef14c26d7fc4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/bee7e7f7-ef5f-01d8-e775-2202258ed174"},"effectiveDateTime":"2014-12-04T19:45:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"560f7ef5-c4a5-7e56-6f6f-38c0c0f42994","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/4068f902-7eb8-e912-def7-589ae9f43d3e"},"effectiveDateTime":"2014-12-07T22:19:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1505ce27-befd-61eb-0c3f-6d85e9652517","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c36d679b-4c23-7166-36a8-41a35d3fad69"},"effectiveDateTime":"2014-12-11T00:41:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"22fc570a-0148-229b-9f2f-167db00c5469","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e33d7ff2-e698-25e7-f047-9f1132edfb37"},"effectiveDateTime":"2014-12-27T04:32:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47d3a820-05b9-29c1-0aff-9f5b3245cba9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3e2aea8f-64d3-2e5d-8e40-a5c49466db55"},"effectiveDateTime":"2014-12-30T07:26:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3bc20b99-a4cd-c703-93b0-82732c7c9689","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/07d0b3e7-26db-7f86-6896-ec3650928ca5"},"effectiveDateTime":"2015-01-02T10:15:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8c77845e-bb49-4ac0-7fb5-9dbe7526b834","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/095a7a91-59a0-af8f-0999-3c493a01065f"},"effectiveDateTime":"2015-01-05T13:53:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c9973d37-d385-c707-2185-b5126b4f968e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/4b73a735-855b-2703-4139-c9b38d71a935"},"effectiveDateTime":"2015-01-08T16:00:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"476e64d3-ea87-81b5-16f4-bcc262e337b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3ffa0235-1715-960e-7ba0-1c4231529f69"},"effectiveDateTime":"2015-01-11T19:13:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c0f51b66-0466-6584-4ec3-48c37ccbe46c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/da4f04bd-a1d2-3d3a-4470-68a1702f43f3"},"effectiveDateTime":"2015-01-14T22:28:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0bb74c7a-473b-be57-8730-d5a116c21645","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/659f8f62-67bd-fddd-4337-92368f57cfbe"},"effectiveDateTime":"2015-01-31T03:59:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cccc437a-e406-d12c-bb48-3c6376d65784","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/13695fff-811b-3446-e648-6dc310b176b7"},"effectiveDateTime":"2015-02-03T06:11:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0e5d48df-a577-7816-6e17-3ac9cfe6b62f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/201af78d-05e4-0f6e-138a-da2492e4abd6"},"effectiveDateTime":"2015-02-06T09:42:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"267db683-e077-5817-e079-1ef2bfb57176","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9ecb9f52-e6b1-6c75-e301-19de11f0e347"},"effectiveDateTime":"2015-02-21T03:38:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0f82b94a-43b3-ff2e-004d-b71a2f00afa8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/93321b39-86c4-ec39-9fc4-1b171435deec"},"effectiveDateTime":"2015-02-24T06:22:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f27e5804-9de6-d395-9f76-bd8385e46cb0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b5f1b88e-1363-92e1-0cde-e11383a0c073"},"effectiveDateTime":"2015-02-27T08:27:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8db3afe4-b673-7cdc-c073-23e77e36cb58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e22acf94-cfd5-2c0a-b886-ed7f9b5debc6"},"effectiveDateTime":"2015-03-02T10:40:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86acdd55-827d-7798-6eba-6c6fcf75dd17","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5f0d471b-80e0-2821-c8cc-7f88a38ec959"},"effectiveDateTime":"2015-03-05T13:13:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"22f1bb26-9227-759b-9f24-7a9a9d006c51","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3468844a-2dc9-bdb9-fb78-a6c8941f9b1b"},"effectiveDateTime":"2015-03-08T18:03:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5be72d4b-35d0-4aca-5e58-612ccbcbeb41","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3cfb0d29-7dfc-521c-91ec-cd7dcf9c57de"},"effectiveDateTime":"2015-03-11T21:09:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d20e034f-c9d1-da07-20bb-7bb548b9ffcc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6eeddc70-a12d-2706-9af6-f38e0522ad2c"},"effectiveDateTime":"2015-03-14T23:51:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ed12abc2-e2ae-c968-03fd-4f815ee188dd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/da42f3ba-de4d-d054-45e5-821892cf3f8a"},"effectiveDateTime":"2015-03-18T03:02:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea4378ca-b1e6-7dba-4606-b6e411a08b31","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6a18d854-f50d-e335-4734-7e7adb2ceb5c"},"effectiveDateTime":"2015-03-21T05:45:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df4746a6-039b-8a79-1d37-a1f37c010962","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9fb73d0d-c9a7-92ac-0797-97943da325c9"},"effectiveDateTime":"2015-03-24T09:09:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f306ddfd-7abd-5edc-f6d6-64556941bea8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/911f4d92-1870-0daf-dc05-43eb728f7b8e"},"effectiveDateTime":"2015-03-27T12:10:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"802f08c8-5c88-e17f-ac26-4b3821dc4942","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c68baee7-9adb-d526-e37c-93d475d021da"},"effectiveDateTime":"2015-03-30T14:35:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23ee024a-4db2-b3f8-d94b-7aafcc9b0a0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d69ef7ff-044b-47f4-66fb-4a6a596385b9"},"effectiveDateTime":"2015-04-02T18:08:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"271b5d93-4f18-2605-e9ac-45567b0f68f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f2a4ab86-e153-03ae-7de7-458a9eb20edb"},"effectiveDateTime":"2015-04-05T20:52:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"659bf1db-195b-7a79-cb1a-da4131b67771","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d35ee980-232f-264a-9878-a94e494edd0b"},"effectiveDateTime":"2015-04-08T23:26:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d427c3e-6780-94bd-006e-7381d8efd225","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/451a9af8-14f3-29ee-f6e6-6435e34e2429"},"effectiveDateTime":"2015-04-12T02:47:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fbe21b1-684c-818e-0616-1038cb50295e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/fc3eb525-5aa5-cae1-5fb9-b4f2a10a6d7c"},"effectiveDateTime":"2015-04-15T05:26:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"747e567e-8ffd-6a7e-6bc2-48a91fe52daa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a9eb163d-bf2d-d773-f4e9-aecdf489b3c4"},"effectiveDateTime":"2015-04-18T08:46:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"abd5cec4-c27c-b8f6-945c-08adef751e75","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e83d2d89-e2a0-cb05-f8b5-d3ee647266b3"},"effectiveDateTime":"2015-04-21T10:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3f58a8dd-a601-65b6-369d-1ab4896928e2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e33f1b85-b54a-d61a-216a-7ea7ee77305a"},"effectiveDateTime":"2015-04-24T13:31:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8bd25623-d6a4-d3ea-16ab-9014a1a2a517","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5edd93fc-bb91-cc65-45c7-1dccc5034433"},"effectiveDateTime":"2015-04-27T16:28:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fce204dd-a46e-ddeb-20c1-bb59d72e523b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/4f7e7ba0-bb85-42b8-a228-b6598d5396af"},"effectiveDateTime":"2015-04-30T19:07:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f8c67ec5-c25a-c675-1226-38ef57f659b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/161fd601-614e-e56c-a6da-50738f89eb6c"},"effectiveDateTime":"2015-05-03T22:13:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"471b9d35-6f37-59bd-0a47-947ae1b07b25","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/aed6aeef-92c3-b974-2c2f-cdd8e8c0c6d2"},"effectiveDateTime":"2015-05-07T00:31:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e891cd14-860e-c7b9-d71d-310e50de4e11","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/dab7e223-05f1-a2a4-590b-e55022b7e374"},"effectiveDateTime":"2015-05-10T02:31:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"adf483a1-5965-17ae-dd88-6e68977e7768","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b77c0383-c8fa-d75a-cdbc-af213f564681"},"effectiveDateTime":"2015-05-13T05:40:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a096e0f8-4609-e94b-f8d5-5d2b057e4c78","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d7a8397d-f8fc-2db8-ca3d-860cd6f930e6"},"effectiveDateTime":"2015-05-16T08:38:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"49486e6c-c876-f9b7-037c-05ad9bb51317","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f458e328-4053-4e03-2bab-ab503fcc9153"},"effectiveDateTime":"2015-05-19T11:17:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c27f278-204f-583c-abe2-280e5bae9655","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9d668c75-3788-1c3d-e3de-71deb84e065d"},"effectiveDateTime":"2015-05-22T13:42:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b9be7d6b-43fd-6bd8-b105-70d06f652f04","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8ea1b547-059d-4626-57a7-0ce50eafd649"},"effectiveDateTime":"2015-05-25T16:59:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c5f44ea-60de-5bed-80d2-7f9acf5a8eac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2ca040c8-b3b7-3bae-0578-ac1fc1205e70"},"effectiveDateTime":"2015-05-28T19:52:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f5c3061-8c45-7629-833d-c65d2fff0f63","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9abdd648-5c5a-c910-7f30-3c0c0ab300b6"},"effectiveDateTime":"2015-05-31T21:53:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"45c66bd5-4bdb-da78-ab45-54cbbd2fc770","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/4a3deb1d-c8d0-d915-302d-e7b566758ecc"},"effectiveDateTime":"2015-06-04T00:51:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66fff528-bc23-8b13-441f-c7d98fc297c3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2afc9db1-7f7b-cf74-0f5b-6ee0e040bc87"},"effectiveDateTime":"2015-06-07T04:44:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47bc94af-762a-a9c1-0ae8-8bf7aaa3e0a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/16b5bc83-22af-dbf3-26c6-b3f248d81f13"},"effectiveDateTime":"2015-06-10T07:04:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ffb59a9d-266c-5ee2-39d5-0d9108025a87","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/00ec7aa4-d7e3-0c83-e760-1328aef525d4"},"effectiveDateTime":"2015-06-13T09:22:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"19856c80-2d11-3723-2635-49a3018b78c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2fe73fc3-7ece-2eaf-708c-5396a8205d7b"},"effectiveDateTime":"2015-06-16T12:57:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e5ffef0-a4ab-aa32-6237-656043b85a0f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3aa80372-8c74-19ac-72da-7ebc2ac3cb8f"},"effectiveDateTime":"2015-06-19T16:22:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"237da9a5-8a32-f42b-9fb0-691a1d8e4869","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/cc0dce2f-0ac5-2a72-cf47-79433be54f20"},"effectiveDateTime":"2015-06-22T18:46:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23fce05f-3a79-c0dd-0592-dc03f5beb9d1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2a543dac-36fa-0ce1-ca2b-8766a85c193d"},"effectiveDateTime":"2015-06-25T22:18:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c9e6e164-079b-e7d7-d615-5d96c7108346","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c8dc2824-9473-f8c6-6145-88f81ef2a92d"},"effectiveDateTime":"2015-06-29T01:20:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a9164bd8-21a9-28d4-f30d-c80b096c54cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5ba39af3-52df-1a42-3c8d-cc10f575f8fb"},"effectiveDateTime":"2015-07-02T04:32:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23606b17-85c6-dfeb-9f93-2a8c2943eb31","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f76627fe-9c9a-a800-9186-83f442cdddbd"},"effectiveDateTime":"2015-07-05T07:29:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f478473-2216-3b0c-36be-2b899e48fa81","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9949d659-e033-ca97-5e05-fb5015ac5323"},"effectiveDateTime":"2015-07-08T09:35:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3027f513-3814-2cbc-7ae7-32b244c409eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6c316164-46b4-5871-a818-4992cf8f6ef8"},"effectiveDateTime":"2015-07-25T06:11:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14eca886-b8bf-664c-3adf-51563f1754e4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9c36f020-e6ac-c325-93b2-c575d1780e29"},"effectiveDateTime":"2015-07-28T09:05:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7223eccb-17ff-07c3-f1c2-f97af5305694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/69264d26-2d83-4162-738d-cadc8499f40b"},"effectiveDateTime":"2015-07-31T12:30:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8464ba13-2203-8d3f-4dae-aa819e364cb4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/ac4f570c-960f-23f4-3072-9995cdddf353"},"effectiveDateTime":"2015-08-03T16:08:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"11db5cb2-3ca0-b26e-02a6-5a8571be73c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5b1d1423-9584-3358-af79-20f835f8a970"},"effectiveDateTime":"2015-08-06T18:31:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bf0ee435-c21f-199e-95de-6a8db0b942d6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/89a791af-affc-d27c-4ab8-73a9b3541645"},"effectiveDateTime":"2015-08-09T21:15:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8613c0bb-eabc-4e3b-35b2-cd6bc7f19ee6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/0f78d018-be46-208b-8957-01ea08f9a65e"},"effectiveDateTime":"2015-08-12T23:18:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4bd7721-3e97-c926-43ca-26fe74e7ffc2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/81bbb4aa-bdfd-cfbb-b54e-db917a59bbd4"},"effectiveDateTime":"2015-08-16T01:44:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd021f34-a479-adb7-f456-1db843865d94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b048cead-0e83-eec8-f3c3-437d41c43d0e"},"effectiveDateTime":"2015-08-19T05:24:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a8d92ba6-03c2-9c7e-6b70-76137c281b68","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/1891d27d-8b06-c093-5367-1a12806acb9f"},"effectiveDateTime":"2015-08-22T07:39:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0707e13d-e7c1-d456-7f6d-6027b25508f3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a0bd2eb0-3afd-8f6b-ce2c-3076ded2dd3f"},"effectiveDateTime":"2015-08-25T10:04:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eb87051f-911d-f05c-6070-4a2a6f9a231c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/630256ff-1e71-3961-5ff5-3431bdcb4969"},"effectiveDateTime":"2015-08-28T12:18:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4240194-2abe-80a2-230d-dc1a9fdbf908","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8adc119a-5adb-c526-bb6d-09e4dfe91a5b"},"effectiveDateTime":"2015-08-31T14:44:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"262ef144-362d-088b-201f-bc4209f232d3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/83b353b0-7896-9035-9b8c-225a8b45ec11"},"effectiveDateTime":"2015-09-03T17:50:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0285ffa1-e32f-782d-6240-7a495b0ab646","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/215554ff-116c-d285-e55a-7b0a3b48f619"},"effectiveDateTime":"2015-09-06T20:43:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7d5dbdf-0f52-f5d5-4fa0-d1d803348bd1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/90c9b221-01b3-a19e-53c6-80935d411400"},"effectiveDateTime":"2015-09-10T00:26:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"895720d4-33b2-00b6-bbcd-9d06f326fe18","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6d2ad207-7e1a-2d33-1ceb-c0663b620eda"},"effectiveDateTime":"2015-09-13T03:15:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9302f25e-db09-0f8e-195a-e0ff0783315e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b08af58c-3213-713a-c498-20342a53da52"},"effectiveDateTime":"2015-09-16T05:56:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"871c7a27-d0ff-9427-36f9-bb8417fb3334","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b26d94af-fa01-490f-620c-772eb64c2480"},"effectiveDateTime":"2015-09-19T09:28:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a558d525-05fd-798f-b318-4f15d0fb4db5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/0d985538-748a-98b4-f786-525365835c35"},"effectiveDateTime":"2015-09-22T13:22:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9fcfb8a9-fa01-6704-9720-910987692a30","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/26280948-cd91-7add-ac8c-5571d074ab29"},"effectiveDateTime":"2015-09-25T16:07:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"375290e8-87df-2060-f6c7-a279470d9c92","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3eab3e29-7414-d5f2-65c7-aefa5fd898c5"},"effectiveDateTime":"2015-09-28T19:28:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"70fbcc72-4f3d-be93-13ad-e4e61ec41682","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b4c51951-55e8-8c6f-4fad-1a17ae279178"},"effectiveDateTime":"2015-10-01T22:02:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78df1242-49e9-699d-1f5b-4501bf02f34d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8537885e-2f7d-5bee-531a-2cdcae2a0f23"},"effectiveDateTime":"2015-10-05T00:05:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"81d1ad5b-3226-1cdc-b491-2278b4120358","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/41d21ea8-ac42-44b9-0893-09001bbae8c1"},"effectiveDateTime":"2015-10-08T02:05:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"303b1fe3-5c13-84cf-0d83-82258bb2917f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/465d5c8b-cd9f-d68b-6595-05fed844b3a4"},"effectiveDateTime":"2015-10-11T05:10:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e35d2c87-555f-126a-5f8f-ebfc7af65069","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e560b2b3-719d-7fce-a74e-e1c1f3a1dcda"},"effectiveDateTime":"2015-10-14T08:46:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"41936194-754e-6920-ab16-c957a145bbba","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3843ef54-049a-8976-a2c3-3bc185837849"},"effectiveDateTime":"2015-10-17T12:27:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7983e3c9-7b6b-d48d-b79d-4384123f402c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6d027c30-e4d8-deeb-fed5-fb1122526c6f"},"effectiveDateTime":"2015-10-20T15:02:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7994da9d-00d2-3b7d-b7ae-3a5799ae5be4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/98f8ee7f-c840-6059-944b-a25b772b22d3"},"effectiveDateTime":"2015-10-23T18:52:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f6af0be5-627c-79c5-e11a-a26e6f74df44","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/797c9a9f-0ed6-51f6-7ea9-31e3116a55c3"},"effectiveDateTime":"2015-10-26T22:49:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b2625ef2-f423-77c1-8fb0-d65911c28471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2e201a23-e3e4-51fc-9457-020775fb4b14"},"effectiveDateTime":"2015-10-30T02:43:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b2fdbf3a-5b16-4a6f-cff6-24b945921030","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c4457faf-511b-f2e7-b307-25a44c0fd3f3"},"effectiveDateTime":"2015-11-02T04:40:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1b049b9-b87d-7421-8973-75b10c9ba9c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/688cdea5-538d-3c3a-cb4a-6649aa0083d1"},"effectiveDateTime":"2015-11-05T07:16:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5965ec11-d4d9-9769-97fa-d01971ec36c9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/6f7ce743-1fe8-8def-b355-3c8ed45dab9d"},"context":{"reference":"Encounter/9ca6e739-5a44-8253-1a4f-79884781e635"},"effectiveDateTime":"2020-10-13T19:54:48-04:00"}
{"resourceType":"MedicationAdministration","id":"564e8317-a524-01b4-832b-fb7d240e8d6b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b94b8870-454c-a36e-ba85-16fe09055352"},"effectiveDateTime":"2015-11-08T09:16:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc779032-177a-56ef-0fb5-a991d21f46ea","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e84a864b-a3f2-6ab6-4d3c-eb6414d57041"},"effectiveDateTime":"2015-11-11T12:09:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3ef4693-2601-65cd-eb44-255fc36928f9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/83e3a67b-0107-82d1-c8af-ad0a473c0825"},"effectiveDateTime":"2015-11-14T15:39:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"19e038f9-b126-6d1c-4c9f-ae4b9a85cb98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/dfddfac2-5542-9f7b-6a24-1fbbd3567541"},"effectiveDateTime":"2015-11-17T17:58:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9dade784-45e7-05bd-8571-137b9b46c0f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b4ccad3f-c6cb-2efa-e75b-8a7e8e443772"},"effectiveDateTime":"2015-11-20T21:52:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1baaddc-f84f-52f0-097d-d9d44def3e08","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/846cc43b-4383-82ec-369d-f3046dd4b63a"},"effectiveDateTime":"2015-11-24T00:39:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"49be7de5-d8fd-5f27-4114-5e5c60652253","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a7be0309-3cc6-664e-3732-4c12cc9c00db"},"effectiveDateTime":"2015-11-27T03:51:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e3a708c9-b843-e18b-0f9e-5ee9d72e494f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/7a85e6e4-4ee9-103f-0f35-70558da806da"},"effectiveDateTime":"2015-11-30T06:01:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"baac2929-655d-9512-051e-2d6bcffe8f32","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/6f7ce743-1fe8-8def-b355-3c8ed45dab9d"},"context":{"reference":"Encounter/13f8b92e-3582-4023-e6cf-4bc6105f0093"},"effectiveDateTime":"2021-10-08T20:33:48-04:00"}
{"resourceType":"MedicationAdministration","id":"92ff7570-17fe-a0fd-cff7-daef02caa299","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/1f2e154d-d7e5-adc0-97e8-85b3bc52f2a8"},"effectiveDateTime":"2015-12-03T08:30:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b578f994-7e5f-205a-74ee-639bf4259c8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9aa3bc17-c608-1055-30e5-01541439cedd"},"effectiveDateTime":"2015-12-06T11:33:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"532e77f5-fde7-57ef-b2e9-2ef7c8f69608","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/0e860c90-32e5-a7e7-46c9-eb35c19cf26b"},"effectiveDateTime":"2015-12-09T13:50:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"163e7be6-a823-9ed2-f39a-fc0eddc2ab81","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d023b751-4fba-ca91-7277-5232322fca00"},"effectiveDateTime":"2015-12-12T16:11:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e396e0ed-e9ec-ef0a-d595-5d20a9626515","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/63cd2e9f-9d25-38be-3137-d9bf425c2423"},"effectiveDateTime":"2015-12-15T19:30:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d3e2b98-d01c-6713-29ee-08f7557bd6b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e9de6e61-f3bd-2a6a-431f-4afd9d11b04d"},"effectiveDateTime":"2015-12-18T22:50:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"15d37a9b-8387-7805-758e-39a76996b61e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/0da862de-be5d-97bf-c4d0-e657c76d39a5"},"effectiveDateTime":"2015-12-22T01:34:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8c689203-22a5-3740-0e91-c7b19ed7f6b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/0b4fa900-31c7-ab4a-687d-3e98a05b8f6b"},"effectiveDateTime":"2015-12-25T05:24:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4ee975a3-1da4-37b7-a74b-b161056763ae","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/05041b26-7cdf-0116-37a9-74850274a1bc"},"effectiveDateTime":"2015-12-28T07:34:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47623708-8bce-0eaf-16e8-8ef73d11d6f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d3044200-e3b6-12cb-a1c5-259b7ff52e08"},"effectiveDateTime":"2015-12-31T09:44:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0bf8cf36-0f00-520a-0061-9ebc66ef03cd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c99ed192-3e7a-6c1f-d558-e75aa419b5e2"},"effectiveDateTime":"2016-01-03T11:49:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84fe3fb3-2230-94cf-1713-d8119e635445","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/0f63358e-32c9-b52a-4e85-53be08c4b35a"},"effectiveDateTime":"2016-01-06T14:14:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd59b40c-ff21-8de5-413b-4a08abd22c26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d0d63abe-b5f8-8578-a74c-39810daea9bd"},"effectiveDateTime":"2016-01-09T16:40:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"46a477fe-f5ff-35d3-4251-48b6fc731769","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/27d58e2d-5bbe-e73f-11d5-385c266de056"},"effectiveDateTime":"2016-01-12T19:28:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2cdb5623-a667-9238-d22e-5014716568b0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/bf246bdc-6836-82d2-ebe9-d4adfde988fe"},"effectiveDateTime":"2016-01-15T23:22:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4dbe156-9636-5312-018b-bebf252f24b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/96d2d4fd-20d0-895f-221a-216fe32ff2a5"},"effectiveDateTime":"2016-01-19T03:17:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"79848e2b-4977-a88d-b79d-ede61c92bffc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c1fc6cf3-5df5-bcc0-3fcb-5a5206e95419"},"effectiveDateTime":"2016-01-22T05:26:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ce094dc-f86e-a0ec-b73c-2b592b2e16a5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5b75627d-43cc-2043-a3c6-85fe9e968c53"},"effectiveDateTime":"2016-02-06T04:35:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1b5844b-ffc7-da06-0978-b0435b9f122a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/2496d1cd-4478-2e4e-bdeb-f79baa23cbeb"},"effectiveDateTime":"2016-02-09T06:39:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd8a8b20-a4a5-b488-2de9-c56043b26466","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/51224807-c470-eee2-c7be-16f9ef4fad07"},"effectiveDateTime":"2016-02-12T09:54:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8af1543c-10dd-fe95-00c5-e197975a3155","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b585fd08-043f-bffa-815d-0d700edac8fa"},"effectiveDateTime":"2016-02-27T05:17:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f9cca563-2251-ce18-d26c-54d99e848d8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a891c854-97ac-d97c-2807-06630a9402f0"},"effectiveDateTime":"2016-03-01T09:11:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c8ff9a4a-21a7-5c2d-26ca-4550896a8825","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6a9f3a36-32ef-4c9b-17b7-2c733b0755f1"},"effectiveDateTime":"2016-03-04T12:33:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8cef5789-80de-943b-02d0-10348f5ac6fb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/1d332e01-67e2-b0fc-5148-376bc1c40d12"},"effectiveDateTime":"2016-03-07T16:08:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3a23da76-980a-e07c-9765-f9b4b16a9b6e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f1114d9a-6c5a-2c40-3cac-c6a71229d78e"},"effectiveDateTime":"2016-03-10T18:50:33-05:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a52c0123-6833-5ce1-d3fa-1ec274e33a5b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a746bfd1-f849-2759-70b6-0ee1b3fda6a7"},"effectiveDateTime":"2016-03-13T22:27:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"48188530-c0c9-2a6b-dfeb-535aa5e6780e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/b2ea16de-61ad-0b91-fe6f-08b1a1431429"},"context":{"reference":"Encounter/9078f5cc-4b9a-5b9b-c016-bf6a69847108"},"effectiveDateTime":"2012-10-22T22:15:24-04:00"}
{"resourceType":"MedicationAdministration","id":"98e6b571-cb6e-dd82-c4de-143e03134545","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6b5a571b-f71b-cfa9-7835-061b02c41be2"},"effectiveDateTime":"2016-03-17T01:37:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e16e102-d2a5-5a3a-6925-5d35921b4af8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8d5ba36e-4afa-b9dc-2284-62330fc346e7"},"effectiveDateTime":"2016-03-20T03:48:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c5c3ac0-587f-3061-380b-e086627311f7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/bd5f45c9-f77d-1275-c1cf-0901a02d2709"},"effectiveDateTime":"2016-03-23T05:58:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c195b486-ae59-bc6a-d7c4-0a5634b1ab29","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/62679756-1532-d226-32e0-0db59a318c14"},"effectiveDateTime":"2016-03-26T08:00:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"79b656be-47ca-8175-b7cf-b679462c8210","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/658f5819-f6d7-0c5c-72e7-013760c21180"},"effectiveDateTime":"2016-03-29T11:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7c2dcecc-539a-b986-0285-bd8c6c64ac56","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/75ca86a5-1ca5-3142-a5cf-89ad51f3b237"},"effectiveDateTime":"2016-04-01T14:39:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77a55c0f-8f51-25d1-27cb-6be58332bbcd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a7fde6f4-46b3-4449-8ed7-5c87f6b9c2c4"},"effectiveDateTime":"2016-04-04T16:54:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c777f41-3ec5-ccde-13b5-98a0f9ca33d1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/693ea25b-4b9b-f8e1-e0f4-f9c86ac15e95"},"effectiveDateTime":"2016-04-07T20:20:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a5bc2923-5e3a-dd23-dd1a-e0c26aeabaa6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/81dab625-c28d-abf4-e12f-66a8942e8da7"},"effectiveDateTime":"2016-04-11T00:02:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86b22c47-0c58-a0d6-ff17-ab332e2be263","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/314ff001-2778-8806-cd6b-2c8b2ba92e34"},"effectiveDateTime":"2016-04-14T03:29:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"98deef80-07e5-5157-275b-223f7dfa35b9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f18476f4-ce0c-7110-8b46-13a31d8692b4"},"effectiveDateTime":"2016-04-17T05:40:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e52cd33e-5d57-62c6-bf1d-9e3c35bae2f9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8b6adf8e-ae00-e4d5-26bd-eaf9c992cebf"},"effectiveDateTime":"2016-04-20T07:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"12248cff-aa90-4b23-1ed4-6a86e72874c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/6a41fbeb-733e-2b7c-2cba-bed40f3fadc6"},"effectiveDateTime":"2016-04-23T11:49:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c1170ec2-4e3e-8113-4003-50ba524bf979","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f296f3ef-490e-8ac0-2d19-5db30bfb7367"},"effectiveDateTime":"2016-04-26T15:05:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2351c809-894f-a56b-9f84-877fae5d1101","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/bba4f5cb-7b0a-4c54-dc49-38a53e40a1b2"},"effectiveDateTime":"2016-04-29T18:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03d55d23-445e-f7ff-47fe-72c2510ed589","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/b68d39cd-5d3b-ec92-d3f1-f63e7b9edf15"},"effectiveDateTime":"2016-05-02T21:43:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a52e1ac5-77af-89f4-ff1e-e5c35063c36f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c332d002-dc9b-9702-3fbe-23e820379d89"},"effectiveDateTime":"2016-05-06T00:07:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c0ebdec4-31be-185c-bec4-e163ddd80927","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/91893466-482f-bbec-1543-8aec2363a017"},"effectiveDateTime":"2016-05-21T05:29:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"115c7679-8f55-316d-0227-7452a2198e47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/0c7dc49e-0007-c840-9f8e-ada8a1661e74"},"effectiveDateTime":"2016-05-24T08:43:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"237d744e-a84e-e5af-e165-377a9fb370b5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f3088e79-5f5b-44d7-2a53-f2084582c139"},"effectiveDateTime":"2016-05-27T11:14:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"33755a5c-3bfd-6ae0-2ada-261308e52e0c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/51564551-52fe-fa9d-94b3-f4b5b187fe4e"},"effectiveDateTime":"2016-05-30T14:36:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"202b2527-d1ee-a85f-01c1-20da57fd7753","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/eb5a6333-b73a-f88e-0145-f46326ef3c9d"},"effectiveDateTime":"2016-06-02T17:38:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5c3ab43-3f31-00b6-93ef-8e72e4cd6e29","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/b2ea16de-61ad-0b91-fe6f-08b1a1431429"},"context":{"reference":"Encounter/5ff31d1e-3eb1-5d2e-09e0-fd0b7434ae5a"},"effectiveDateTime":"2019-10-17T21:49:35-04:00"}
{"resourceType":"MedicationAdministration","id":"97ef211f-286b-078e-1e47-0fe9c156995e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/1167614d-d53b-d1a7-8730-05a5aa3a74cb"},"effectiveDateTime":"2016-06-05T20:36:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd816e0f-89e9-3e06-b6e9-313b814eca80","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/092e659b-3ca5-ab1f-9b7e-b15ccd930450"},"effectiveDateTime":"2016-06-08T23:11:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f5bfef38-f17a-dd82-21b7-550588c74546","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/4c625e1a-eca5-fa5b-cd84-f6f69337d560"},"effectiveDateTime":"2016-06-12T01:53:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56a44218-9496-0bfd-eed4-da4c33a2bbda","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a331c8e7-b124-daff-d136-67bff726a7a1"},"effectiveDateTime":"2016-06-15T03:56:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4f09341-5482-c0cf-01ad-0ca917aeb836","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e5f626ab-ec92-b0b8-0a69-70bcd0b55cba"},"effectiveDateTime":"2016-06-18T07:11:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"391f4c80-5602-f163-5f9b-7f3fcc6bc741","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d31e369c-ff1e-25e8-389c-0a4434fe0c39"},"effectiveDateTime":"2016-06-21T10:29:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"de23c3c3-8ae1-cb32-e7c2-d073687d04ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/36b346ba-9801-35a5-8e34-9bfa996c57eb"},"effectiveDateTime":"2016-06-24T14:13:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"798e5f9f-49d4-c13d-b7a7-bf5a825171c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/f4e056ae-075c-11f0-4824-d8321f346f12"},"effectiveDateTime":"2016-06-27T18:12:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77148047-507f-301f-72c8-28a323b311b5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/5191e134-e39d-3f01-c87b-259d24c2fcdb"},"effectiveDateTime":"2016-06-30T22:05:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"076cab80-ce9c-fb23-141c-8922fc468ec2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/54590b8a-c23d-dad8-bf74-9422d3315ea0"},"effectiveDateTime":"2016-07-16T04:44:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6add1ced-962d-5d4f-56b7-0db894079027","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/ddf229a1-1f7a-1362-487d-af44093f7f56"},"effectiveDateTime":"2016-07-19T07:15:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d6ee9625-ba0e-c622-a130-9016850ca065","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8265191e-ad40-fd0e-afbd-4abdd762957b"},"effectiveDateTime":"2016-07-22T09:34:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1f3bf7c8-4f58-5113-f1d1-8bf81edea901","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/122697e1-e437-969b-9703-b87d30b74658"},"effectiveDateTime":"2016-07-25T11:42:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"94af0bd5-511e-ffef-139c-3d4d488bf855","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/3b30c9f6-d629-13b7-fa71-c26bd3fd0250"},"effectiveDateTime":"2016-07-28T15:23:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5970739f-28d9-216c-3fba-a8530a6f1d21","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/79600f8c-661d-c3b8-3ef0-dd6479a85233"},"effectiveDateTime":"2016-07-31T18:55:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08f46742-0057-4f1a-c444-d26d6f956879","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/a5b498ee-2e07-c10f-b03d-8a81935a549a"},"effectiveDateTime":"2016-08-03T22:26:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"627ed9b4-a47a-7eb6-0ff5-3b0043872e94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/37bc1d66-61d9-8365-5b81-8fa3769ac997"},"effectiveDateTime":"2016-08-20T06:08:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"12ff2e02-1312-8399-cff7-9381008641a8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/860bd066-0c65-9599-4bdd-4fc6fdd906ef"},"effectiveDateTime":"2016-08-23T09:06:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"90c4b9ca-1a22-ab37-0687-f79ab4194c69","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/de31737f-9104-0904-d09e-cf63f1866da5"},"effectiveDateTime":"2006-08-29T21:23:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0655d8d-a2eb-7e5b-77ec-4550cee2ea39","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/8b5216b6-56e7-81b3-037c-9f3e08875ebc"},"effectiveDateTime":"2016-08-26T11:20:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0b17b08-fccf-7839-306c-dbf6cdbab653","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/9b7af5b6-7f90-6faf-f7e5-b2a63a66e814"},"effectiveDateTime":"2016-08-29T13:59:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23f9b3b3-14e4-60dd-058f-af694434ee51","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e252c05b-fe0c-941a-ad0f-d807ba31113d"},"effectiveDateTime":"2016-09-01T17:36:33-04:00","reasonReference":[{"reference":"Condition/cc838c00-f89a-6dc3-8a86-4bbaf07c658b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4147cfbf-735e-52da-29a4-cecb4c193479","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/8488a085-b511-c98a-ca45-18be489a82e4"},"effectiveDateTime":"2006-09-02T00:01:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a138d8ae-4d2a-4f7b-4021-45e19a230a5d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/8ede99bd-7e70-a240-60cf-c13df132daea"},"effectiveDateTime":"2006-09-05T03:32:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b6edf9fa-4a04-9f0a-3409-8af304e63df3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/1d8d2d43-befe-fbb0-32b0-ef2e2f3a83d5"},"effectiveDateTime":"2006-09-08T05:40:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84cb54ad-c8a1-4e18-0f04-0f8f6789db81","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/029a197f-bee6-44df-e560-75e00619d676"},"effectiveDateTime":"2006-09-11T09:38:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8a5ba53d-8970-7cb6-81a0-9299143e53c3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/210666c7-20ea-f93a-6d97-8fa3230f3a27"},"effectiveDateTime":"2006-09-14T13:25:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5842ea3-5d37-580d-253f-8f4ebf4c9627","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c06557b4-1f84-eeb0-3af3-fe17eaf17233"},"effectiveDateTime":"2016-08-29T04:19:03-04:00","reasonReference":[{"reference":"Condition/1a038574-a34b-4033-a394-9ed2061b64c0","display":"Awaiting transplantation of kidney (situation)"}]}
{"resourceType":"MedicationAdministration","id":"91d52175-9187-f522-5cd2-fc802be75713","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c06557b4-1f84-eeb0-3af3-fe17eaf17233"},"effectiveDateTime":"2016-08-30T04:46:18-04:00","reasonReference":[{"reference":"Condition/35ce8419-5339-9f5b-7073-ff7d120a3a22","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"3dc32860-e123-28b5-4aba-6dcd68d4f68c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/b9e293e9-52f5-8539-d153-63d23dec844f"},"effectiveDateTime":"2006-09-17T15:30:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5bf39bd-a604-63f3-c283-1b53a1ba83b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/c06557b4-1f84-eeb0-3af3-fe17eaf17233"},"effectiveDateTime":"2016-08-31T05:19:54-04:00","reasonReference":[{"reference":"Condition/35ce8419-5339-9f5b-7073-ff7d120a3a22","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"b35087b7-8cf0-0596-d735-392d502dd711","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/3847ed07-8ee2-20f8-d848-9b2eae1c19bc"},"effectiveDateTime":"2006-09-20T18:05:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d2a0f99-6a6c-b521-f827-eacdaea13711","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/bdb5f350-f88e-ebb3-6d63-4f767e944cc4"},"effectiveDateTime":"2016-09-07T06:56:14-04:00","reasonReference":[{"reference":"Condition/35ce8419-5339-9f5b-7073-ff7d120a3a22","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"842c86f2-d2ad-1214-fa5b-3f5a8ce07c88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/4bfd4f9b-527c-fecb-e4dd-bdb4c785e2ba"},"effectiveDateTime":"2006-09-23T21:05:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a0f0da3e-7cfe-2b0c-7e61-a9b2ebf8a639","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/92c8153b-bc2a-f464-f19c-631389a8a200"},"effectiveDateTime":"2006-09-27T01:01:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4ac2a7a-02e5-b1db-491b-9f7268649f88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/031ba74c-91a3-3257-b0d1-d656e1cd250c"},"effectiveDateTime":"2016-09-14T08:32:31-04:00","reasonReference":[{"reference":"Condition/35ce8419-5339-9f5b-7073-ff7d120a3a22","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"c9c2f6f5-5fed-49b1-8d00-c8d1a1e17b27","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/19a93cd9-62f9-1526-27b7-3ed8d7ac8a6b"},"effectiveDateTime":"2006-09-30T04:23:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f87646b1-d057-36fe-b3e5-e7dabf95505e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d12f0bcf-9879-231b-404b-bd14452676ed"},"effectiveDateTime":"2016-09-21T10:04:09-04:00","reasonReference":[{"reference":"Condition/35ce8419-5339-9f5b-7073-ff7d120a3a22","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"89ee2313-220c-5459-7245-9e279e3f13d0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/e8b27ab1-2d99-517c-0cc1-b17c5962a535"},"effectiveDateTime":"2016-09-28T11:22:56-04:00","reasonReference":[{"reference":"Condition/35ce8419-5339-9f5b-7073-ff7d120a3a22","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"9f367da9-0d54-2c40-56c1-c8f23135c23c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/db7e967a-6caf-2e9c-1704-efdbb4ab7219"},"context":{"reference":"Encounter/d38ae7e5-1214-ec62-e085-637436d6a271"},"effectiveDateTime":"2016-10-05T12:27:36-04:00","reasonReference":[{"reference":"Condition/35ce8419-5339-9f5b-7073-ff7d120a3a22","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"a3c1239d-1fa5-b708-40bf-40b9fd16867d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/f4957802-a89f-9aa3-e586-f10a8dce0e0b"},"effectiveDateTime":"2006-10-14T21:54:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"68234a65-69bd-3fb9-f3d1-6453fe5c1a18","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/7338644a-8685-f6fe-90f0-20d931b750b3"},"effectiveDateTime":"2006-10-18T00:12:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"461bf1da-bda3-51da-00fd-90c417834df3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/e2605775-61cf-14ff-7b80-733106467c52"},"effectiveDateTime":"2006-10-21T02:31:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"81bbd46b-874b-9654-0837-7a12af9ef940","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/fbf3bb5a-637d-ce03-bff7-150773c4a387"},"effectiveDateTime":"2006-10-24T04:41:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b7dc4ef2-3080-127a-9f13-8f551c068e20","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/7882b466-17c1-e50f-8cff-ec774de5a7c8"},"effectiveDateTime":"2006-10-27T07:19:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"70435f8d-b7d3-a5e6-1e5d-4e26577f8972","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/eed2cc51-acf8-9342-bf41-3ed269916e4e"},"effectiveDateTime":"2006-10-30T09:42:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"499fc757-b0e9-ca22-9671-bbd57ec0d719","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/f54fab7d-d14c-7371-4392-54a5421311fc"},"effectiveDateTime":"2006-11-02T13:30:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d46ab7ce-6fd4-4069-3f0c-75149e8ca824","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/1e6f7a5b-470b-f68a-0312-1eff2436fcaa"},"effectiveDateTime":"2006-11-05T17:23:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0a7c674b-a8d8-e86a-c2e4-21ba48c5de98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/bc32a11f-7d06-3261-01df-ebb27961783c"},"effectiveDateTime":"2006-11-08T19:49:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c580b7db-2de0-9869-7de8-724dd649f698","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/adac0522-665e-0078-df40-04fdc61dff0a"},"effectiveDateTime":"2006-11-11T23:00:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a6f630e7-8916-28a5-b561-febe960d777c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/300ed3f9-4948-631c-7a94-6168a30a3f34"},"effectiveDateTime":"2006-11-15T02:44:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"30f07eda-ac92-d616-5fa8-e695275b5374","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/3b09cf72-b731-8082-83d1-3760ea6eb519"},"effectiveDateTime":"2006-11-18T06:28:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e337fe8f-4af7-0a54-d1d7-b4593e82b86e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/4ecefb4f-b115-e0d9-53fc-11f4d5ecef7f"},"effectiveDateTime":"2006-11-21T10:06:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3500177f-f25d-d608-1f0b-8fa82b18b7a7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/8bbb5793-1ba9-486d-749b-805e3fbb31af"},"effectiveDateTime":"2006-11-24T13:10:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a6f767fd-6658-7b1b-eb1d-3314c28c5866","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/2d92b382-a532-d5fb-aa32-fa27385f9b70"},"effectiveDateTime":"2006-12-09T19:45:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9449ade1-ef70-6f9d-8b9d-003cda3e46aa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/d69bb5aa-9cee-bb72-33df-2e87eaed0af3"},"effectiveDateTime":"2006-12-12T23:05:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"142cf534-9438-f000-125b-ad9c4ed7822c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/49862a87-a85a-b3e1-e5a5-89699c2e9105"},"effectiveDateTime":"2006-12-16T01:36:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ee2e28e3-5493-870d-6ed3-f6ba618adb60","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/a24ff906-7b08-17f6-fc23-abdd2c30a9c3"},"effectiveDateTime":"2006-12-19T04:18:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66bd28d2-56eb-4d41-05a7-c314c1c40823","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/64a421d3-0f34-549e-f20b-72494b6685f2"},"effectiveDateTime":"2006-12-22T06:37:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26be504f-1fe2-ac91-840a-6f8e373ee06e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/8bddde38-6f6a-a739-5679-ab3d1a35f1a4"},"effectiveDateTime":"2007-01-06T20:00:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8b86d06a-cbe8-2349-2529-4e99844fde08","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/e033b7f1-a7f5-bcd3-59f7-8673112cebda"},"effectiveDateTime":"2007-01-09T22:40:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f72126a-c340-5a7d-ffa1-f55649bc06a7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/22513c77-5596-a7f3-c782-000db4fcaef8"},"effectiveDateTime":"2007-01-13T02:08:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2a96e8fe-7a59-9ee8-686d-1e9e678b14ab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/f4671995-5586-e8f0-ee29-ea9e79c411e4"},"effectiveDateTime":"2007-01-16T05:43:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"733d6851-cc2b-d316-2e08-174ad25a8b7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/10b60a3d-389f-3cf6-4779-3ffb63727c20"},"effectiveDateTime":"2007-01-19T07:55:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7111bc6b-4868-a9f6-9fca-2426271bd7dc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/70e10b50-03f5-8f8b-2811-e7a9c28c56c0"},"effectiveDateTime":"2007-02-03T21:03:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37bea1c8-e0a5-47b2-fafc-78de835fb927","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/98f2efc1-5ee0-476f-231d-58a9d23afc55"},"effectiveDateTime":"2007-02-06T23:42:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"556d166c-c8a8-853e-29a2-79584f2433a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/b7608664-a96f-cf66-ea70-3bff2ef6e1c5"},"effectiveDateTime":"2007-02-10T01:45:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff4a1429-c52d-c41c-5b7d-f19f1f5ddb34","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/387a7528-7969-d058-4f62-65803b744812"},"effectiveDateTime":"2007-02-13T04:50:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b95a805d-1214-9bd3-88d0-5dce8de17944","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/b7bef095-e193-36b3-c339-c827fc24a96b"},"effectiveDateTime":"2007-02-16T07:43:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4590a15d-2cad-e0db-0072-40493795c514","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/e8613d0b-ad98-65ba-2f26-9dd81f2d60b2"},"effectiveDateTime":"2007-03-03T20:38:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"786ee096-38af-7e7d-f8c5-ed73a97ef48a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/a94ab709-1944-5d1a-a949-b462da3cb2c8"},"effectiveDateTime":"2007-03-06T23:39:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"15a42329-1e1d-b189-f329-8bd65d350dbc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/bd7ba8b5-2d6c-a10f-786a-658e2b5023d7"},"effectiveDateTime":"2007-03-10T03:28:56-05:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c21e3f47-0d26-43ad-b935-9b7aeaada8b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/6f00ff41-331e-48ed-85fa-0419d05d3dd2"},"effectiveDateTime":"2007-03-13T06:30:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"516eb825-c61d-ff0a-2ef8-1b5935355b3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/b2c1bc66-c314-9ba4-ea5e-e057750961f1"},"effectiveDateTime":"2007-03-16T08:48:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"22a430c3-801b-9272-0e2a-ac74ecb1e2d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/458071ad-44fe-c9c4-1edf-eb729530db7e"},"effectiveDateTime":"2007-03-19T11:35:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"48ccea3b-2d8d-1ed7-7caa-779d40743633","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/37a186bc-2a2d-52ba-c9eb-3a7020a5b203"},"effectiveDateTime":"2007-03-22T13:46:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"94df637d-1ea5-893e-f453-7ed9fc1658b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/e28e8689-e4ca-370b-f065-9d2e1bc83cbd"},"effectiveDateTime":"2007-04-07T20:30:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0cb49ec7-a2f5-49b2-cff2-7865755afb27","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/689fb94d-f834-97fe-0bcc-2f516e70491e"},"effectiveDateTime":"2007-04-10T23:05:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"413d3a1e-2fb2-4935-7909-2afc5e6ab0f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/3c67d1a9-1c24-8c21-2dc2-423b66cea141"},"effectiveDateTime":"2007-04-14T02:56:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e6bfb69-96ba-5de6-0c85-ea388d353f72","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/8b0a78d7-fc82-ec42-69ea-ab1e38a119c9"},"effectiveDateTime":"2007-04-17T06:31:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e7559879-9168-80c0-debd-95b0ef3657cd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/ba6c6015-ca70-d22e-8225-0bea2f826646"},"effectiveDateTime":"2007-04-20T10:14:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"52895b7f-2355-bebe-b574-e1fad89232d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/fd9361c0-eb24-e9ec-d801-c974f878da5a"},"effectiveDateTime":"2007-05-05T20:33:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"332c03ac-32e6-f2af-2201-f84b7272a0c9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/12e443e0-4d35-d7f5-45fe-3c143482784f"},"effectiveDateTime":"2007-05-08T23:56:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"58636f7c-9ea8-8555-1019-d7797c1954cc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/ce27ef25-cc42-6d41-b8f1-b311b84da1bc"},"effectiveDateTime":"2007-05-12T03:08:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8c1a115d-2087-d19a-4be8-4ff9fdf8a111","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/3361b61c-ad90-7d29-627e-83b54c8f4b0b"},"effectiveDateTime":"2007-05-15T06:34:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ec567d2-9e14-65f6-1cdf-56ab99777d82","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/7b63b08f-f669-ace1-3601-9451f7e235c3"},"effectiveDateTime":"2007-05-18T09:36:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"72449d54-98cb-4f52-5ed1-7ac568423f16","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/afe2b79b-f9e9-7104-dd8d-36a30503c3fd"},"effectiveDateTime":"2007-06-02T21:35:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"18d31672-8e31-0520-018f-f95e14acbcde","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/333855f9-5210-9f5f-5ee4-6322ff617667"},"effectiveDateTime":"2007-06-05T23:54:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c432465b-3d1a-519e-0995-31e1b8d24fc6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/7ebf3e9a-e6f6-bafd-be67-60a653a6dd69"},"effectiveDateTime":"2007-06-09T02:45:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"990541cc-662a-2e2f-00c0-c5b003e85ce8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/04df8988-5de8-93a2-caf7-e89fe45029ba"},"effectiveDateTime":"2007-06-12T05:24:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ba0281d-72a6-fe70-62ef-7f34cedadc34","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/648086cf-cedb-399b-518e-85024636b1e7"},"effectiveDateTime":"2007-06-15T08:46:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"97e5489d-1fce-bd14-afc0-44e9fd3f8c8b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/8bdb4514-4745-0c20-97cf-1458f701e79b"},"effectiveDateTime":"2007-06-18T11:15:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9018ee0d-2db4-1437-05dc-2be9ad487169","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/a745beca-3b55-f1a9-df6f-27a997aeac85"},"effectiveDateTime":"2007-06-21T14:11:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e3f691a-c247-30ac-6b36-ddb912fbfe83","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/c07ac6ee-3e99-8a15-8aca-7d403beef88f"},"effectiveDateTime":"2007-07-07T21:39:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"250e3b7e-f2e6-f58c-13f8-7c318272a3a6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/9f6946eb-6929-569a-e83e-e826dc2aeec9"},"effectiveDateTime":"2007-07-11T01:24:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b7466ff9-905d-1ea5-eb24-46781b483601","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/484e0765-46b5-7429-1edb-309f0bec1203"},"effectiveDateTime":"2007-07-14T03:33:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a9f96c71-8903-dc1c-062d-4a4a04b49334","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/9d8ee786-49fd-adf0-faa3-33d20fa4e4dc"},"effectiveDateTime":"2007-07-17T05:42:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a42cbc97-62ad-a457-7a5b-74ff1e62ab88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/d56192fa-46ad-1ffc-ec9d-7d097624b945"},"effectiveDateTime":"2007-07-20T09:25:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e3f64af9-94cf-e8d6-ac71-e02b0a9326b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/cc33ee1e-1d4b-35a8-fff8-820aaf39f1ae"},"effectiveDateTime":"2007-07-23T12:35:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"65364dfc-816d-f0ba-dc99-3982fd29c2aa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/bafb5a8c-b540-993c-bd7a-b3a650a1ab00"},"effectiveDateTime":"2007-07-26T16:17:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c68935c-b6d5-e6f2-3436-6a69ae502829","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/8d09c1ff-608d-419f-0f4f-e1f44975e757"},"effectiveDateTime":"2007-08-11T22:12:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"054cbf69-08fa-2358-e6eb-aec12fecdc12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/901145e5-53ab-3bb3-2b98-6c7731a1fbc1"},"effectiveDateTime":"2007-08-15T00:46:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aed38f57-6a47-7092-1fa3-070b75171d70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/5bf4b61e-4eb5-4def-4f96-e61959a2577f"},"effectiveDateTime":"2007-08-18T03:01:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"638bbbdb-d766-502f-8590-c9d48aec3d64","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1860480","display":"1 ML DOCEtaxel 20 MG/ML Injection"}],"text":"1 ML DOCEtaxel 20 MG/ML Injection"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/7ba9e8b8-cf78-9d1d-cf16-02b23c0e8b27"},"effectiveDateTime":"2007-03-25T08:50:15-04:00","reasonReference":[{"reference":"Condition/1c1b1089-8db9-cfd3-1c03-7af29b154e4f","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"345df81a-4084-e3d2-dd6e-208a0621133b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"752899","display":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"}],"text":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/7ba9e8b8-cf78-9d1d-cf16-02b23c0e8b27"},"effectiveDateTime":"2007-03-25T08:50:15-04:00","reasonReference":[{"reference":"Condition/1c1b1089-8db9-cfd3-1c03-7af29b154e4f","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"87365245-b11d-5009-b619-3dcc2cdb3129","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/da1f221c-417d-35be-fe92-10bf6c3d6853"},"effectiveDateTime":"2007-08-21T06:30:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b2e51e35-1e89-c386-0f11-fba5ee0187a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/9d14bc19-dc6e-9c8b-8026-d57279dd49ad"},"effectiveDateTime":"2007-08-24T08:45:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8bb43106-4531-e027-f2c0-0be4aff5d418","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1860480","display":"1 ML DOCEtaxel 20 MG/ML Injection"}],"text":"1 ML DOCEtaxel 20 MG/ML Injection"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/781dd59c-4131-197e-0e84-e2ded7e4d440"},"effectiveDateTime":"2007-06-23T14:03:15-04:00","reasonReference":[{"reference":"Condition/1c1b1089-8db9-cfd3-1c03-7af29b154e4f","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"a3b4cec7-b854-0e33-1472-7cae64934d4a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"752899","display":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"}],"text":"0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/781dd59c-4131-197e-0e84-e2ded7e4d440"},"effectiveDateTime":"2007-06-23T14:03:15-04:00","reasonReference":[{"reference":"Condition/1c1b1089-8db9-cfd3-1c03-7af29b154e4f","display":"Neoplasm of prostate"}]}
{"resourceType":"MedicationAdministration","id":"b127859e-1c49-def6-7efe-9295990af425","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/05cf50b7-6875-342b-d34d-e5055bfdfafd"},"effectiveDateTime":"2007-08-27T10:57:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b0e7131f-8050-b5b5-0e72-c1396f4b3839","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/f79b0d99-f0d9-b04f-b2ec-398cf43a3f0a"},"effectiveDateTime":"2007-08-30T13:37:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23582ee3-d276-0af2-e238-7f713561916d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/1df8cf61-39bb-63bd-f347-cb65dbff1ffc"},"effectiveDateTime":"2007-09-02T15:49:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47e36ea4-e6b2-4211-c3a2-8e8434952d97","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/12c42b3a-cc3a-eec4-2ecf-f6c9b52f1889"},"effectiveDateTime":"2007-09-05T17:52:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"033ae7e2-8ed1-28c0-1032-66a21ab5f697","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/8900ad38-6497-da0a-05b0-9b592c3b04a0"},"effectiveDateTime":"2007-09-08T20:19:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"32464fc5-f59a-6db8-9a02-49c3f3589c70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/ee4671d2-4eaa-a558-5acb-2075ae59fa51"},"effectiveDateTime":"2007-09-11T23:00:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8ce7ab12-6d00-7ab9-02aa-e8f25cf260eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/a6b68799-4c1a-042e-bca9-e6d010827565"},"effectiveDateTime":"2007-09-15T01:35:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"528fda44-7abc-96b9-b57b-60c03bcdb149","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/790b2f90-cb7c-4b7a-7cd9-9dd4867cc8a0"},"effectiveDateTime":"2007-09-29T21:11:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"769a166b-9a5f-4e15-5a82-f95720db0f66","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/5ee782aa-b91e-468d-fd1f-d2985bf157aa"},"effectiveDateTime":"2007-10-02T23:30:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1190ff57-b91a-1ca3-c58c-16b3ecf8292a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/b44b5317-dd36-a288-378d-2ba9afec839b"},"effectiveDateTime":"2007-10-06T02:09:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4eea2fec-1ee6-e131-3df1-787864728f4b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/ab5bf318-c1e7-ea3b-d809-78b6570c5b4f"},"effectiveDateTime":"2007-10-09T06:05:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"29c61eec-c717-b445-5b3b-e22aa8208b59","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/cace50bf-e152-4b6d-bdd4-567a672f00de"},"effectiveDateTime":"2007-10-12T08:07:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4ae962be-d874-9acb-1a61-acf9af71783c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/ee03ae23-e591-2483-9a2d-63dd15e962a7"},"effectiveDateTime":"2007-10-15T10:52:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86e58f27-5a84-608d-54fd-48fb94da54f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"212033","display":"aspirin 325 MG Oral Tablet"}],"text":"aspirin 325 MG Oral Tablet"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/6d0a2428-089b-eb9d-f247-f71920d75e5c"},"effectiveDateTime":"2008-08-03T08:28:18-04:00","dosage":{"dose":{"value":4}}}
{"resourceType":"MedicationAdministration","id":"ea3c09b3-e04b-a70a-a44b-3b29a3898853","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/b9a97e0e-6a14-e36a-a7de-af72526063ac"},"context":{"reference":"Encounter/1a7ff0a6-6ac2-9971-e123-e4936cb5ea59"},"effectiveDateTime":"2007-10-18T12:59:56-04:00","reasonReference":[{"reference":"Condition/9053dde6-060d-55ef-cbbf-298d0aebeb2b","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"64b3d4fa-09dc-73c3-5328-e38f86d52749","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198039","display":"nitroglycerin 0.4 MG Sublingual Tablet"}],"text":"nitroglycerin 0.4 MG Sublingual Tablet"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/6d0a2428-089b-eb9d-f247-f71920d75e5c"},"effectiveDateTime":"2008-08-03T08:28:18-04:00"}
{"resourceType":"MedicationAdministration","id":"f717f27f-3da6-e9ed-0d88-b04ddf79998d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1728805","display":"2 ML morphine sulfate 1 MG/ML Injection"}],"text":"2 ML morphine sulfate 1 MG/ML Injection"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/6d0a2428-089b-eb9d-f247-f71920d75e5c"},"effectiveDateTime":"2008-08-03T08:28:18-04:00"}
{"resourceType":"MedicationAdministration","id":"70bb2a03-1d44-96e3-8874-fe454338f9b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"763138","display":"reteplase 10 UNT Injection"}],"text":"reteplase 10 UNT Injection"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/333fd513-4a93-753e-6e2e-c9b20b4128b1"},"effectiveDateTime":"2008-08-03T08:45:22-04:00"}
{"resourceType":"MedicationAdministration","id":"3c367be7-e26a-bf3a-01d2-ab5b8aef0b22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1361048","display":"heparin sodium, porcine 100 UNT/ML Injectable Solution"}],"text":"heparin sodium, porcine 100 UNT/ML Injectable Solution"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/333fd513-4a93-753e-6e2e-c9b20b4128b1"},"effectiveDateTime":"2008-08-03T08:45:22-04:00"}
{"resourceType":"MedicationAdministration","id":"144e7306-27aa-a7ed-fb9f-7b9df735e04b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1116635","display":"ticagrelor 90 MG Oral Tablet"}],"text":"ticagrelor 90 MG Oral Tablet"},"subject":{"reference":"Patient/8bc23b3d-756c-306f-28aa-98a1f8e4e0b3"},"context":{"reference":"Encounter/333fd513-4a93-753e-6e2e-c9b20b4128b1"},"effectiveDateTime":"2008-08-03T08:45:22-04:00"}
